###begin article-title 0
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 114 114 114 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2"/>
Leptin-dependent Phosphorylation of PTEN Mediates Actin Restructuring and Activation of ATP-sensitive K+ Channels*
###end article-title 0
###begin p 1
Present address: Academic Neurology Unit, The University of Sheffield Medical School, Sheffield, S10 2RX, UK.
###end p 1
###begin p 2
###xml 207 233 207 233 <email xmlns:xlink="http://www.w3.org/1999/xlink">m.l.j.ashford@dundee.ac.uk</email>
 To whom correspondence should be addressed: Biomedical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY UK. Tel.: 44-1382-632497; Fax: 44-1382-667120; E-mail: m.l.j.ashford@dundee.ac.uk.
###end p 2
###begin p 3
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 3
###begin p 4
 applies to Author Choice Articles
###end p 4
###begin p 5
###xml 1069 1070 1066 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Leptin activates multiple signaling pathways in cells, including the phosphatidylinositol 3-kinase pathway, indicating a degree of cross-talk with insulin signaling. The exact mechanisms by which leptin alters this signaling pathway and how it relates to functional outputs are unclear at present. A previous study has established that leptin inhibits the activity of the phosphatase PTEN (phosphatase and tensin homolog deleted on chromosome 10), an important tumor suppressor and modifier of phosphoinositide signaling. In this study we demonstrate that leptin phosphorylates multiple sites on the C-terminal tail of PTEN in hypothalamic and pancreatic beta-cells, an action not replicated by insulin. Inhibitors of the protein kinases CK2 and glycogen synthase kinase 3 (GSK3) block leptin-mediated PTEN phosphorylation. PTEN phosphorylation mutants reveal the critical role these sites play in transmission of the leptin signal to F-actin depolymerization. CK2 and GSK3 inhibitors also prevent leptin-mediated F-actin depolymerization and consequent ATP-sensitive K+ channel opening. GSK3 kinase activity is inhibited by insulin but not leptin in hypothalamic cells. Both hormones increase N-terminal GSK3 serine phosphorylation, but in hypothalamic cells this action of leptin is transient. Leptin, not insulin, increases GSK3 tyrosine phosphorylation in both cell types. These results demonstrate a significant role for PTEN in leptin signal transmission and identify GSK3 as a potential important signaling node contributing to divergent outputs for these hormones.
###end p 5
###begin p 6
###xml 27 41 27 41 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
###xml 48 54 48 54 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink">068692</grant-num>
###xml 73 89 73 89 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Tenovus Scotland</grant-sponsor>
###xml 97 163 97 163 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Biotechnology and Biological Sciences Research Council Studentship</grant-sponsor>
This work was supported by Wellcome Trust Grant 068692 (to M. L. J. A.), Tenovus Scotland, and a Biotechnology and Biological Sciences Research Council Studentship (to L. C. M.).
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 673 674 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 815 816 815 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">3</xref>
###xml 909 910 909 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 912 913 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
Efficient signaling by leptin and insulin is essential for the maintenance of body energy homeostasis, with disruptions in these processes strongly associated with diabetes and obesity (1, 2) and, at least for insulin, neurodegenerative disorders such as Alzheimer disease (3, 4). In recent years there has been a significant increase in understanding the intracellular signaling processes associated with the actions of insulin on a wide variety of cell types (5). However, our knowledge of leptin signaling is less advanced, with most studies indicating that leptin and insulin share many signaling intermediates in common, often leading to similar cellular outcomes (6, 7). In particular, signaling through the STAT (signal transducers and activators of transcription), mitogen-activated protein kinase, and PI3K3 pathways have been reported extensively in numerous cell types for both leptin and insulin (5, 8).
###end p 8
###begin p 9
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 613 614 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 916 917 916 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1045 1048 1045 1048 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1142 1144 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1214 1217 1214 1217 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1298 1300 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1301 1303 1301 1303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1382 1385 1382 1385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1450 1451 1450 1451 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1582 1584 1582 1584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1062 1065 <span type="species:ncbi:10116">rat</span>
###xml 1099 1102 <span type="species:ncbi:10116">rat</span>
###xml 1107 1112 <span type="species:ncbi:10090">mouse</span>
Nevertheless, leptin and insulin can cause differing and sometimes opposing cellular outputs, even on the same cell type. This is demonstrated in hypothalamic neurons, where electrophysiological or imaging studies show differential outcomes for leptin and insulin action (9-11). Thus, although superficially leptin may utilize the same signaling pathways as insulin, the exact nature of the leptin-induced signaling intermediates and their interplay with one another and with individual effectors is still relatively unknown. Recently, it was demonstrated that although leptin, like insulin, raises PtdIns(3,4,5)P3 levels in hypothalamic cells, the mechanism underlying the increase by leptin differs from that of insulin. Whereas insulin increased PI3K activity, leptin had little effect on PI3K activity. Instead, leptin inhibited the lipid and protein phosphatase, PTEN, which resulted in increased PtdIns(3,4,5)P3 levels in the presence of active PI3K (12). Previously, PI3K-dependent leptin signaling had been shown to open ATP-sensitive (KATP) channels in rat hypothalamic neurons (13) and in rat and mouse insulin-secreting cells (12, 14, 15), resulting in cell hyperpolarization and inhibition of firing. KATP activation by leptin is dependent on actin depolymerization in both cell types (12-15). The connection between leptin-driven PI3K activity, actin re-modeling, and KATP opening appears not to be due simply to increased PtdIns(3,4,5)P3 but may also require coincident inhibition of PTEN protein and lipid phosphatase activity through increased PTEN phosphorylation (12).
###end p 9
###begin p 10
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1245 1247 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 1329 1330 1329 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1323 1330 1323 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1338 1346 1338 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1362 1364 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1366 1368 1366 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 1431 1433 1431 1433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 1524 1529 <span type="species:ncbi:9606">human</span>
In this study we have focused on the mechanisms by which leptin alters PTEN phosphorylation in hypothalamic and insulin-secreting cells. The biological activity of PTEN toward anionic lipid substrates is considered to be dependent on its phosphorylation status at various residues between Ser-362 and Ser-385, located in the PTEN C-terminal tail (Fig. 1A), with phosphorylation maintaining PTEN in an inactive state (16). The major sites of phosphorylation are Ser-370 and Ser-385 (17, 18), with significant phosphorylation at a cluster of sites (Ser-380, Thr-382, and Thr-383) close to Ser-385. Mutations of the cluster site residues have significant effects on PTEN stability and membrane and protein binding (17, 19, 20). It is thought that PTEN is constitutively phosphorylated and not linked to physiological signaling events such as stimulation of cells with insulin or growth factors (21, 22). However, we previously demonstrated that leptin stimulation of hypothalamic cells reduced PTEN phosphatase activity and increased PTEN phosphorylation at the cluster site (12). This increased phosphorylation was sensitive to inhibition of protein kinase CK2, previously implicated as the main kinase phosphorylating PTEN at these residues (17, 18). CK2 has also been reported to phosphorylate PTEN at Ser-370 and Ser-385 (Fig. 1A) using in vitro kinase assays (17, 23), resulting in a 30% depression of PTEN phosphatase activity (18). In addition, GSK3beta has been reported to phosphorylate PTEN at Ser-362 and Thr-366 in human embryonic kidney 293T cells, with Thr-366 phosphorylation reducing the biological activity of PTEN.
###end p 10
###begin p 11
###xml 265 268 265 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
Consequently, we have assessed whether leptin mediates phosphorylation of PTEN at Ser-370, Ser-385, and Thr-366 in a CK2- and GSK3-dependent manner and further examined the contribution of Ser-370 and Thr-366 to downstream events such as actin re-organization and KATP channel opening using hypothalamic and insulin-secreting cells.
###end p 11
###begin title 12
EXPERIMENTAL PROCEDURES
###end title 12
###begin p 13
###xml 0 32 0 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Culture and Islet Isolation</italic>
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 294 295 294 295 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 370 373 370 373 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m l</sc>
###xml 391 392 390 391 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 494 495 493 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 919 921 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 355 359 <span type="species:ncbi:9913">calf</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
Cell Culture and Islet Isolation-The mouse hypothalamic cell line N29/4 was cultured as previously described (24). MIN6 cells (obtained with permission from Jun-ichi Miyazaki, Osaka University) were used between passages 24 and 30 and grown in Dulbecco's modified Eagle's medium containing 25 mm glucose and supplemented with 12.5% heat-inactivated fetal calf serum, 4 mm l-glutamine, 100 mum 2-mercaptoethanol, and 1% penicillin and streptomycin in a humidified atmosphere of 95% air and 5% CO2. Wild-type C57Bl/6 mice (20-25 g) were used for islet isolation and killed by cervical dislocation immediately before the islet isolation procedure. All animal procedures conformed to the UK Animals (Scientific Procedures) Act 1986 and were approved by our institutional ethical review committee. Pancreatic islets were isolated from mice under sterile conditions, and isolated cells were cultured as described previously (12).
###end p 13
###begin p 14
###xml 0 47 0 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cell Transfection, Staining, and Actin Analysis</italic>
###xml 600 601 590 591 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 954 955 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1036 1038 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 1063 1064 1053 1054 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1074 1075 1064 1065 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1084 1085 1074 1075 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1090 1091 1080 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1096 1097 1086 1087 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1102 1103 1092 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1109 1110 1099 1100 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1280 1282 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1514 1516 1504 1506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1640 1642 1630 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1713 1714 1703 1704 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2060 2061 2050 2051 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1430 1434 <span type="species:ncbi:9925">goat</span>
###xml 1815 1820 <span type="species:ncbi:10090">mouse</span>
Cell Transfection, Staining, and Actin Analysis-N29/4 cells were plated in 6-well plates at 40% confluence 24 h before transfection. 5 mul of Lipofectamine (Invitrogen) and 2 mug of PTEN DNA were mixed with 100 mul of serum-free Opti medium, incubated at room temperature for 20 min to form the transfection complexes, and diluted with 500 mul of culture medium. The mixture was applied to the cells, left overnight at 37 degreesC, replaced with culture medium, and incubated for 48 h before use. In experiments where wild-type and mutant PTEN constructs were overexpressed, F-actin or PtdIns(3,4,5)P3 levels were determined from 60 cells for control and each treatment from a total of 4 experiments (comparing transfected cells, as determined by PTEN antibody staining, with control cells). Similarly, 72 cells were examined from 4 experiments to measure F-actin in control and leptin with or without CT99021 and/or 2-dimethyl-amino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT). Cells were treated with DMAT (Calbiochem) and/or CT99021 (25) in normal saline (135 mm NaCl, 5 mm KCl, 1 mm MgCl2, 1 mm CaCl2, 10 mm HEPES, and 0.2% BSA, pH 7.4) for 20 min before challenge with leptin or saline in the continuous presence of inhibitor for 60 min before fixing as described previously (13). For staining, cells were washed in phosphate-buffered saline (PBS), permeabilized in PBS, 0.5% Triton X-100 for 10 min, rinsed, blocked with 20% goat serum (Sigma), and incubated with rhodamine-conjugated phalloidin or 2 units ml-1 Alexa 488-phalloidin (Molecular Probes) for 90-120 min. Immunocytochemical staining was performed as described previously (13) using a monoclonal antibody against PTEN (Chemicon) or PtdIns(3,4,5)P3 (Molecular Probes). The secondary antibodies were Cy3 or fluorescein isothiocyanate-conjugated anti-mouse IgG (Jackson ImmunoResearch). Fluorescence-labeled proteins or lipids in cells were observed with a 63x oil objective, and images were acquired by confocal microscopy (Zeiss LSM 510). For quantitative analysis of F-actin and PtdIns(3,4,5)P3 levels, Aida/two-dimensional densitometry was used to measure pixel intensity of defined areas of transfected, treated, and control cells. After subtraction of background, intensity values for treated cells were expressed as a ratio of control cell intensity.
###end p 14
###begin p 15
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Western Blotting</italic>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
Western Blotting-N29/4 and MIN6 cells, grown in 6-well plates, were exposed to normal saline for 30 min before treatment with leptin, insulin, or saline in the presence and absence of LY294002 (Sigma), DMAT, or CT99021 for the required time (inhibitors added 20-30 min before challenge). Protein isolation, content, immunoblotting, and analysis procedures were as previously described (13). PTEN and phospho-PTEN antibodies, Ser-380/Thr-382/Thr-383 were from Cell Signaling (1:5000), Ser-385 was from BIOSOURCE (1:500), and Ser-370 and Thr-366 were from Nick Leslie (1:500). phosphorylated (p)-PKB (Ser-473) and p-GSK3 (Ser-9/Ser-21) were obtained from Cell Signaling and used at 1:1000. p-GSK3 (Tyr-216/Tyr-279), PKB, and GSK3 antibodies (all polyclonal) were obtained from BD Transduction Laboratories and used at 1:2500 (p-GSK3) and 1:1000 (PKB and GSK3). Monoclonal anti beta-actin antibody (used at 1:10000) was from MP Biochemicals. Protein bands on gels were quantified by densitometry, where total density was determined with respect to constant area, background was subtracted, and average relative band density was calculated.
###end p 15
###begin p 16
###xml 0 37 0 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Immunoprecipitation and Assay of GSK3</italic>
###xml 332 333 319 320 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 380 381 367 368 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 405 406 392 393 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 582 583 560 561 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 607 608 585 586 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 673 674 648 649 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 679 680 654 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 687 688 662 663 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 696 698 667 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 713 714 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 734 735 705 706 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 903 904 874 875 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 906 907 877 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 909 910 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
Immunoprecipitation and Assay of GSK3-Cell extracts (0.5 mg) were incubated with protein G-Sepharose conjugated to 2.5 mg of anti-GSK3alpha/beta antibody, Upstate Biotechnology, Inc. (Lake Placid, NY) for 1 h at 4 degreesC on a shaking platform. The immunocomplexes were pelleted and washed with 1 ml of lysis buffer containing 0.5 m NaCl and twice with 1 ml of assay buffer (50 mm Tris-HCl, pH 7.5, 150 mm NaCl, 0.03% (v/v) Brij-35, and 0.1% (v/v) beta-mercaptoethanol). The immunoprecipitated GSK3 was incubated at 30 degreesC for 20 min in a total volume of 50 ml containing 50 mm Tris-HCl, pH 7.5, 100 mm NaCl, 0.03% (v/v) Brij-35, 0.1% (v/v) beta-mercaptoethanol, 10 mm MgCl2, 0.1 mm [gamma-32P]ATP (0.5 x 106 cpm/nmol), and 30 mm phosphoglycogen synthase 2 peptide (available from Upstate). Radiolabeled peptide produced was separated from unreacted ATP by binding to P81 paper and washing in 75 mm H3PO4 before counting in 2 ml of scintillant. One unit of kinase activity is defined as the amount that catalyzes the phosphorylation of 1 nmol of substrate in 1 h.
###end p 16
###begin p 17
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 98 9 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibitors of CK2 and GSK3 reduce leptin-mediated phosphorylation of PTEN in N29/4 cells.</bold>
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bold</italic>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 472 473 472 473 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 520 521 519 520 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 528 529 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 530 531 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 538 539 536 537 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 549 550 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 551 553 549 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 565 566 562 563 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 577 578 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 579 581 576 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 584 585 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 591 601 588 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 719 720 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 753 754 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 778 779 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 780 781 777 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 796 797 793 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 798 800 795 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 802 803 799 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 819 820 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 822 832 819 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 943 944 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1008 1009 1005 1006 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 9 1018 9 1015 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18"><bold>Inhibitors of CK2 and GSK3 reduce leptin-mediated phosphorylation of PTEN in N29/4 cells.</bold><italic>A</italic>, schematic representation of PTEN. The sequence of amino acids for part of the C-terminal tail domain is shown, with the main phosphorylation sites denoted in <italic>bold</italic>, and the putative phosphorylating kinase shown <italic>below</italic>. <italic>B</italic>, phosphorylated PTEN levels in N29/4 cells using the phospho-specific PTEN antibodies indicated under non-stimulated conditions (<italic>C</italic>), in response to 10 n<sc>m</sc> leptin alone (<italic>L</italic>), and in the presence of 10 &#956;<sc>m</sc> DMAT (<italic>L</italic>+<italic>D</italic>), 2 &#956;<sc>m</sc> CT99021 (<italic>L</italic>+<italic>CT</italic>), and 10 &#956;<sc>m</sc> LY294002 (<italic>L</italic>+<italic>LY</italic>). <italic>C</italic>, the <italic>bar graphs</italic> show mean normalized levels of phosphorylated PTEN at Ser-385, Ser-370, and Thr-366 under non-stimulated conditions (<italic>C</italic>) and for leptin in the absence (<italic>L</italic>) and presence of DMAT (<italic>L</italic>+<italic>D</italic>) and CT99021 (<italic>L</italic>+<italic>CT</italic>; <italic>n</italic> = 6 for each). <italic>D</italic>, <italic>bar graphs</italic> showing mean normalized levels of phosphorylated PTEN at Thr-366 and Ser-370 under non-stimulated conditions (<italic>C</italic>) and after stimulation of N29/4 cells for 5 or 30 min with 10 n<sc>m</sc> insulin.</p>
###xml 9 1018 9 1015 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18"><bold>Inhibitors of CK2 and GSK3 reduce leptin-mediated phosphorylation of PTEN in N29/4 cells.</bold><italic>A</italic>, schematic representation of PTEN. The sequence of amino acids for part of the C-terminal tail domain is shown, with the main phosphorylation sites denoted in <italic>bold</italic>, and the putative phosphorylating kinase shown <italic>below</italic>. <italic>B</italic>, phosphorylated PTEN levels in N29/4 cells using the phospho-specific PTEN antibodies indicated under non-stimulated conditions (<italic>C</italic>), in response to 10 n<sc>m</sc> leptin alone (<italic>L</italic>), and in the presence of 10 &#956;<sc>m</sc> DMAT (<italic>L</italic>+<italic>D</italic>), 2 &#956;<sc>m</sc> CT99021 (<italic>L</italic>+<italic>CT</italic>), and 10 &#956;<sc>m</sc> LY294002 (<italic>L</italic>+<italic>LY</italic>). <italic>C</italic>, the <italic>bar graphs</italic> show mean normalized levels of phosphorylated PTEN at Ser-385, Ser-370, and Thr-366 under non-stimulated conditions (<italic>C</italic>) and for leptin in the absence (<italic>L</italic>) and presence of DMAT (<italic>L</italic>+<italic>D</italic>) and CT99021 (<italic>L</italic>+<italic>CT</italic>; <italic>n</italic> = 6 for each). <italic>D</italic>, <italic>bar graphs</italic> showing mean normalized levels of phosphorylated PTEN at Thr-366 and Ser-370 under non-stimulated conditions (<italic>C</italic>) and after stimulation of N29/4 cells for 5 or 30 min with 10 n<sc>m</sc> insulin.</p></caption>
###xml 1018 1018 1015 1015 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972430001"/>
###xml 0 1018 0 1015 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="18"><bold>Inhibitors of CK2 and GSK3 reduce leptin-mediated phosphorylation of PTEN in N29/4 cells.</bold><italic>A</italic>, schematic representation of PTEN. The sequence of amino acids for part of the C-terminal tail domain is shown, with the main phosphorylation sites denoted in <italic>bold</italic>, and the putative phosphorylating kinase shown <italic>below</italic>. <italic>B</italic>, phosphorylated PTEN levels in N29/4 cells using the phospho-specific PTEN antibodies indicated under non-stimulated conditions (<italic>C</italic>), in response to 10 n<sc>m</sc> leptin alone (<italic>L</italic>), and in the presence of 10 &#956;<sc>m</sc> DMAT (<italic>L</italic>+<italic>D</italic>), 2 &#956;<sc>m</sc> CT99021 (<italic>L</italic>+<italic>CT</italic>), and 10 &#956;<sc>m</sc> LY294002 (<italic>L</italic>+<italic>LY</italic>). <italic>C</italic>, the <italic>bar graphs</italic> show mean normalized levels of phosphorylated PTEN at Ser-385, Ser-370, and Thr-366 under non-stimulated conditions (<italic>C</italic>) and for leptin in the absence (<italic>L</italic>) and presence of DMAT (<italic>L</italic>+<italic>D</italic>) and CT99021 (<italic>L</italic>+<italic>CT</italic>; <italic>n</italic> = 6 for each). <italic>D</italic>, <italic>bar graphs</italic> showing mean normalized levels of phosphorylated PTEN at Thr-366 and Ser-370 under non-stimulated conditions (<italic>C</italic>) and after stimulation of N29/4 cells for 5 or 30 min with 10 n<sc>m</sc> insulin.</p></caption><graphic xlink:href="zbc0190972430001"/></fig>
FIGURE 1.Inhibitors of CK2 and GSK3 reduce leptin-mediated phosphorylation of PTEN in N29/4 cells.A, schematic representation of PTEN. The sequence of amino acids for part of the C-terminal tail domain is shown, with the main phosphorylation sites denoted in bold, and the putative phosphorylating kinase shown below. B, phosphorylated PTEN levels in N29/4 cells using the phospho-specific PTEN antibodies indicated under non-stimulated conditions (C), in response to 10 nm leptin alone (L), and in the presence of 10 mum DMAT (L+D), 2 mum CT99021 (L+CT), and 10 mum LY294002 (L+LY). C, the bar graphs show mean normalized levels of phosphorylated PTEN at Ser-385, Ser-370, and Thr-366 under non-stimulated conditions (C) and for leptin in the absence (L) and presence of DMAT (L+D) and CT99021 (L+CT; n = 6 for each). D, bar graphs showing mean normalized levels of phosphorylated PTEN at Thr-366 and Ser-370 under non-stimulated conditions (C) and after stimulation of N29/4 cells for 5 or 30 min with 10 nm insulin.
###end p 17
###begin p 18
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Inhibitors of CK2 and GSK3 reduce leptin-mediated phosphorylation of PTEN in N29/4 cells.</bold>
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bold</italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 463 464 463 464 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 479 480 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 511 512 510 511 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 519 520 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 521 522 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 529 530 527 528 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 540 541 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 542 544 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 556 557 553 554 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 568 569 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 570 572 567 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 575 576 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 582 592 579 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 710 711 707 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 744 745 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 769 770 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 771 772 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 787 788 784 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 789 791 786 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 793 794 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 810 811 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 813 823 810 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 934 935 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 999 1000 996 997 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Inhibitors of CK2 and GSK3 reduce leptin-mediated phosphorylation of PTEN in N29/4 cells.A, schematic representation of PTEN. The sequence of amino acids for part of the C-terminal tail domain is shown, with the main phosphorylation sites denoted in bold, and the putative phosphorylating kinase shown below. B, phosphorylated PTEN levels in N29/4 cells using the phospho-specific PTEN antibodies indicated under non-stimulated conditions (C), in response to 10 nm leptin alone (L), and in the presence of 10 mum DMAT (L+D), 2 mum CT99021 (L+CT), and 10 mum LY294002 (L+LY). C, the bar graphs show mean normalized levels of phosphorylated PTEN at Ser-385, Ser-370, and Thr-366 under non-stimulated conditions (C) and for leptin in the absence (L) and presence of DMAT (L+D) and CT99021 (L+CT; n = 6 for each). D, bar graphs showing mean normalized levels of phosphorylated PTEN at Thr-366 and Ser-370 under non-stimulated conditions (C) and after stimulation of N29/4 cells for 5 or 30 min with 10 nm insulin.
###end p 18
###begin p 19
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Electrophysiology</italic>
###xml 1040 1041 1031 1032 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1050 1051 1041 1042 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1056 1057 1047 1048 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1064 1065 1055 1056 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1070 1071 1061 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1076 1077 1067 1068 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1089 1090 1080 1081 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1101 1102 1092 1093 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1126 1128 1117 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1138 1139 1129 1130 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 18 23 <span type="species:ncbi:10090">Mouse</span>
Electrophysiology-Mouse cultured beta-cells were superfused at room temperature (22-25 degreesC) with normal saline. Wholecell current and voltage clamp recordings were used to monitor membrane potential and macroscopic current, respectively, using an Axopatch 200B amplifier. Whole-cell experiments were maintained in current-clamp mode to monitor the cell resting membrane potential, with short excursions into voltage clamp mode to examine macroscopic current-voltage relations. In voltage-clamp recordings the membrane potential was held at -70- and 20-mV steps of 2 s duration, with 20 ms between pulses applied (range of voltages, -160 to -40 mV). Whole cell voltage clamp data were analyzed using pCLAMP 8.2 software (Molecular Devices). Current clamp data were recorded and stored onto digital audio tapes and replayed for analysis and illustration on a Gould TA240 chart recorder. Recording electrodes were pulled from borosilicate glass and had resistances of 5-10 megaohms when filled with pipette solution, which comprised 140 mm KCl, 5 mm MgCl2, 3.8 mm CaCl2, 3 mm MgATP, 10 mm EGTA, 10 mm HEPES, pH 7.2 (free [Ca2+] of 100 nm). Application of drugs was made via the bath perfusion system except for DMAT and the GSK3 inhibitors, which were present in the pipette solution.
###end p 19
###begin p 20
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Statistical Analysis</italic>
###xml 166 167 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 203 204 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistical Analysis-Data are presented as the means +/- S.E. unless otherwise stated. All statistical analyses were performed using analysis of variance, one sample t test, Student's paired or unpaired t tests. A probability level of 0.05 was considered significant.
###end p 20
###begin title 21
RESULTS
###end title 21
###begin p 22
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 146 153 146 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 187 188 187 188 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 206 207 206 207 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 290 291 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 284 291 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 475 476 474 475 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 478 479 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 500 501 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 494 501 493 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 620 622 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 624 626 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 628 630 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 680 682 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 835 837 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 839 841 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 883 885 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 887 889 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 904 905 899 900 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1005 1006 1000 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1011 1012 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 997 1012 992 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>C</italic></xref>
###xml 1091 1092 1085 1086 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1184 1185 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1190 1191 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1176 1191 1170 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>B</italic> and <italic>C</italic></xref>
###xml 1211 1212 1205 1206 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1220 1221 1214 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1214 1221 1208 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 1230 1231 1224 1225 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
We used the leptin- and insulin-sensitive hypothalamic cell line N29/4 (12, 24) to examine PTEN phosphorylation at Thr-366, Ser-370, and Ser-385 (Fig. 1A) on stimulation with leptin (10 nm) or insulin (10 nm). Leptin rapidly (<5 min) increased the level of p-PTEN at all three sites (Fig. 1B), an action sustained for at least 60 min for each site (data not shown). This leptin-mediated increase in p-PTEN was unaffected by the presence of the PI3K inhibitor, LY294002 (10 mum; n = 6 for each; Fig. 1B). Previous studies indicated that the cluster site, Ser-385 and Ser-370, may be phosphorylated by protein kinase CK2 (17, 18, 23), and Thr-366 may be phosphorylated by GSK3beta (23). Consequently, we examined leptin phosphorylation of Thr-366, Ser-370, and Ser-385 PTEN residues in the absence and presence of DMAT (a CK2 inhibitor (26, 27) and CT99021 (a specific GSK3 inhibitor (28, 29)). DMAT (10 mum) prevented leptin from phosphorylating Ser-370 and Ser-385 but not Thr-366 in N29/4 cells (Fig. 1, B and C). Conversely, leptin phosphorylation of Thr-366 was prevented by CT99021 (2 mum), whereas phosphorylation of Ser-370 and Ser-385 was unaffected by this inhibitor (Fig. 1, B and C). In contrast, 10 nm (Fig. 1D) or 50 nm (data not shown) insulin had no effect on p-PTEN levels in N29/4 cells at Thr-366 or Ser-370 residues, with the Ser-385 site not tested.
###end p 22
###begin p 23
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 710 711 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 789 790 789 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 973 979 973 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 1032 1033 1032 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1026 1033 1026 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 1101 1102 1101 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1165 1166 1165 1166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1293 1294 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1299 1300 1299 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1285 1300 1285 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, <italic>A</italic> and <italic>B</italic></xref>
###xml 1383 1384 1383 1384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1399 1400 1399 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1393 1400 1393 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 1539 1540 1539 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1533 1540 1533 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 1621 1622 1621 1622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1632 1638 1632 1638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 1738 1739 1738 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1732 1739 1732 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 1803 1805 1803 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1847 1848 1847 1848 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Leptin re-organization of the actin cytoskeleton is dependent on PI3K activity and inhibition of the lipid and protein phosphatase activity of PTEN. Overexpression of cluster site p-PTEN mutants demonstrated that phosphorylation at this site was required to limit PTEN phosphatase activity and prevent leptin-induced F-actin depolymerization (12). Accordingly, we have examined whether phosphorylation of PTEN at Ser-370 and/or Thr-366 is also required for transmission of the leptin signal to F-actin. First, we sought to determine whether phosphorylation of Thr-366 or Ser-370 altered the activity of PTEN in cells by overexpression of PTEN mutants with alanine or aspartic acid substitutions. PtdIns(3,4,5)P3 and F-actin levels were assessed by staining with a monoclonal PtdIns(3,4,5)P3 antibody and Alexa 488-conjugated phalloidin respectively, after transfection of PTEN mutants into N29/4 cells. In control experiments overexpression of wild-type PTEN had no effect per se but prevented leptin from decreasing F-actin (Fig. 2A). Overexpression of T366A PTEN or S370A PTEN reduced PtdIns(3,4,5)P3 levels (data not shown), indicative of enhanced PtdIns(3,4,5)P3 phosphatase activity, did not affect F-actin in the absence of leptin and inhibited leptin-induced F-actin reduction (Fig. 2, A and B). In contrast, overexpression of T366D PTEN or S370D PTEN increased PtdIns(3,4,5)P3 levels (Fig. 2C). The presence of the 366D PTEN mutant in N29/4 cells decreased F-actin levels in the absence of leptin in a PI3K-dependent manner (Fig. 2D). Surprisingly, overexpression of S370D PTEN, although increasing PtdIns(3,4,5)P3, did not per se alter F-actin staining in the absence of leptin nor occlude the effect of leptin on F-actin (Fig. 2E). This action of S370D PTEN indicates, as observed previously (12), that increasing cellular PtdIns(3,4,5)P3 levels alone is not a predictor or indeed sufficient to initiate PTEN-dependent downstream signaling events such as F-actin depolymerization.
###end p 23
###begin p 24
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 9 101 9 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of PTEN phosphorylation mutants on PtdIns(3,4,5)P<sub>3</sub> and F-actin levels in N29/4 cells.</bold>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 190 202 190 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 325 337 325 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 375 376 375 376 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 477 495 477 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right lower panels</italic>
###xml 545 555 545 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar graphs</italic>
###xml 660 661 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 678 679 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 690 691 688 689 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 755 756 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 772 773 770 771 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 878 879 876 877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 894 903 892 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 939 940 937 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1037 1038 1035 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1043 1044 1041 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1078 1090 1076 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1120 1132 1118 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 1151 1152 1149 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1169 1170 1167 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1188 1192 1186 1190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 1208 1213 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 1223 1224 1220 1221 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1235 1237 1232 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 1239 1240 1236 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1249 1250 1246 1247 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1259 1260 1256 1257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1267 1277 1264 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 1364 1365 1361 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1382 1383 1379 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1441 1442 1438 1439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1502 1503 1499 1500 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1544 1545 1540 1541 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1561 1563 1557 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 1593 1594 1588 1589 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1601 1602 1596 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1733 1742 1728 1737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 1912 1913 1905 1906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 1915 1916 1908 1909 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1990 2000 1983 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bars</italic>
###xml 2007 2008 1999 2000 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2013 2014 2005 2006 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2010 2014 2002 2006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP<sub>3</sub></italic>
###xml 2030 2031 2022 2023 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 9 2032 9 2024 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><bold>Effect of PTEN phosphorylation mutants on PtdIns(3,4,5)P<sub>3</sub> and F-actin levels in N29/4 cells.</bold> Wild-type PTEN and T366A PTEN (<italic>A</italic>) and S370A PTEN (<italic>B</italic>) were overexpressed in N29/4 cells (<italic>upper panels</italic>, Cy3 secondary antibody on cells treated with monoclonal PTEN antibody) and F-actin visualized with Alexa 488-phalloidin (<italic>lower panels</italic>) with and without stimulation by 10 n<sc>m</sc> leptin. Note that untransfected cells in the leptin (<italic>L</italic>)-treated group are not easily visible in the <italic>right lower panels</italic> due to leptin-mediated F-actin depolymerization. <italic>Bar graphs</italic> showing mean levels of F-actin after treatment of N29/4 cells &#177; overexpression of PTEN or T366A PTEN (<italic>A</italic>) or S370A PTEN (<italic>B</italic>) with 10 n<sc>m</sc> leptin. Data are shown as a ratio of control, untreated cells. <italic>C</italic>, PtdIns(3,4,5)P<sub>3</sub> levels in N29/4 cells transfected with T366D PTEN or S370D PTEN were investigated using a PtdIns(3,4,5)P<sub>3</sub> antibody. The <italic>bar graph</italic> shows mean levels of PtdIns(3,4,5)P<sub>3</sub> (as a ratio of control) in N29/4 cells after treatment with these PTEN phosphorylation mutants. <italic>D</italic> and <italic>E</italic>, F-actin levels were visualized (<italic>lower panels</italic>) in N29/4 cells transfected (<italic>upper panels</italic>) with T366D PTEN (<italic>D</italic>) or S370D PTEN (<italic>E</italic>) in the absence (<italic>left</italic>) and presence (<italic>right</italic>) of 10 &#956;<sc>m</sc> LY294002 (<italic>LY</italic>, <italic>D</italic>) or 10 n<sc>m</sc> leptin (<italic>E</italic>). The <italic>bar graphs</italic> show mean levels of F-actin after treatment of N29/4 cells overexpressing T366D PTEN (<italic>D</italic>) or S370D PTEN (<italic>E</italic>). Data are shown as a ratio of control, untreated cells. <italic>F</italic>, cellular F-actin levels in the absence or presence of 10 n<sc>m</sc> leptin and in cells pretreated with 2 &#956;<sc>m</sc> CT99021 alone (<italic>CT</italic>) or in combination with 10 &#956;<sc>m</sc> DMAT (<italic>D</italic>) before leptin challenge. Note that F-actin is visualized in this series of experiments with rhodamine-conjugated phalloidin. The <italic>bar graph</italic> denotes mean levels of F-actin-treated cells. Data are shown as the ratio of control, untreated cells. Values represent the mean &#177; S.E. for 3&#8211;4 experiments per group. <sup>*</sup>, <italic>p</italic> &lt; 0.05 compared with the appropriate labeled control for each treatment. <italic>Scale bars</italic>, 10 &#956;<sc>m</sc>. <italic>PIP<sub>3</sub></italic>, PtdIns(3,4,5)P<sub>3</sub>.</p>
###xml 9 2032 9 2024 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25"><bold>Effect of PTEN phosphorylation mutants on PtdIns(3,4,5)P<sub>3</sub> and F-actin levels in N29/4 cells.</bold> Wild-type PTEN and T366A PTEN (<italic>A</italic>) and S370A PTEN (<italic>B</italic>) were overexpressed in N29/4 cells (<italic>upper panels</italic>, Cy3 secondary antibody on cells treated with monoclonal PTEN antibody) and F-actin visualized with Alexa 488-phalloidin (<italic>lower panels</italic>) with and without stimulation by 10 n<sc>m</sc> leptin. Note that untransfected cells in the leptin (<italic>L</italic>)-treated group are not easily visible in the <italic>right lower panels</italic> due to leptin-mediated F-actin depolymerization. <italic>Bar graphs</italic> showing mean levels of F-actin after treatment of N29/4 cells &#177; overexpression of PTEN or T366A PTEN (<italic>A</italic>) or S370A PTEN (<italic>B</italic>) with 10 n<sc>m</sc> leptin. Data are shown as a ratio of control, untreated cells. <italic>C</italic>, PtdIns(3,4,5)P<sub>3</sub> levels in N29/4 cells transfected with T366D PTEN or S370D PTEN were investigated using a PtdIns(3,4,5)P<sub>3</sub> antibody. The <italic>bar graph</italic> shows mean levels of PtdIns(3,4,5)P<sub>3</sub> (as a ratio of control) in N29/4 cells after treatment with these PTEN phosphorylation mutants. <italic>D</italic> and <italic>E</italic>, F-actin levels were visualized (<italic>lower panels</italic>) in N29/4 cells transfected (<italic>upper panels</italic>) with T366D PTEN (<italic>D</italic>) or S370D PTEN (<italic>E</italic>) in the absence (<italic>left</italic>) and presence (<italic>right</italic>) of 10 &#956;<sc>m</sc> LY294002 (<italic>LY</italic>, <italic>D</italic>) or 10 n<sc>m</sc> leptin (<italic>E</italic>). The <italic>bar graphs</italic> show mean levels of F-actin after treatment of N29/4 cells overexpressing T366D PTEN (<italic>D</italic>) or S370D PTEN (<italic>E</italic>). Data are shown as a ratio of control, untreated cells. <italic>F</italic>, cellular F-actin levels in the absence or presence of 10 n<sc>m</sc> leptin and in cells pretreated with 2 &#956;<sc>m</sc> CT99021 alone (<italic>CT</italic>) or in combination with 10 &#956;<sc>m</sc> DMAT (<italic>D</italic>) before leptin challenge. Note that F-actin is visualized in this series of experiments with rhodamine-conjugated phalloidin. The <italic>bar graph</italic> denotes mean levels of F-actin-treated cells. Data are shown as the ratio of control, untreated cells. Values represent the mean &#177; S.E. for 3&#8211;4 experiments per group. <sup>*</sup>, <italic>p</italic> &lt; 0.05 compared with the appropriate labeled control for each treatment. <italic>Scale bars</italic>, 10 &#956;<sc>m</sc>. <italic>PIP<sub>3</sub></italic>, PtdIns(3,4,5)P<sub>3</sub>.</p></caption>
###xml 2032 2032 2024 2024 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972430002"/>
###xml 0 2032 0 2024 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="25"><bold>Effect of PTEN phosphorylation mutants on PtdIns(3,4,5)P<sub>3</sub> and F-actin levels in N29/4 cells.</bold> Wild-type PTEN and T366A PTEN (<italic>A</italic>) and S370A PTEN (<italic>B</italic>) were overexpressed in N29/4 cells (<italic>upper panels</italic>, Cy3 secondary antibody on cells treated with monoclonal PTEN antibody) and F-actin visualized with Alexa 488-phalloidin (<italic>lower panels</italic>) with and without stimulation by 10 n<sc>m</sc> leptin. Note that untransfected cells in the leptin (<italic>L</italic>)-treated group are not easily visible in the <italic>right lower panels</italic> due to leptin-mediated F-actin depolymerization. <italic>Bar graphs</italic> showing mean levels of F-actin after treatment of N29/4 cells &#177; overexpression of PTEN or T366A PTEN (<italic>A</italic>) or S370A PTEN (<italic>B</italic>) with 10 n<sc>m</sc> leptin. Data are shown as a ratio of control, untreated cells. <italic>C</italic>, PtdIns(3,4,5)P<sub>3</sub> levels in N29/4 cells transfected with T366D PTEN or S370D PTEN were investigated using a PtdIns(3,4,5)P<sub>3</sub> antibody. The <italic>bar graph</italic> shows mean levels of PtdIns(3,4,5)P<sub>3</sub> (as a ratio of control) in N29/4 cells after treatment with these PTEN phosphorylation mutants. <italic>D</italic> and <italic>E</italic>, F-actin levels were visualized (<italic>lower panels</italic>) in N29/4 cells transfected (<italic>upper panels</italic>) with T366D PTEN (<italic>D</italic>) or S370D PTEN (<italic>E</italic>) in the absence (<italic>left</italic>) and presence (<italic>right</italic>) of 10 &#956;<sc>m</sc> LY294002 (<italic>LY</italic>, <italic>D</italic>) or 10 n<sc>m</sc> leptin (<italic>E</italic>). The <italic>bar graphs</italic> show mean levels of F-actin after treatment of N29/4 cells overexpressing T366D PTEN (<italic>D</italic>) or S370D PTEN (<italic>E</italic>). Data are shown as a ratio of control, untreated cells. <italic>F</italic>, cellular F-actin levels in the absence or presence of 10 n<sc>m</sc> leptin and in cells pretreated with 2 &#956;<sc>m</sc> CT99021 alone (<italic>CT</italic>) or in combination with 10 &#956;<sc>m</sc> DMAT (<italic>D</italic>) before leptin challenge. Note that F-actin is visualized in this series of experiments with rhodamine-conjugated phalloidin. The <italic>bar graph</italic> denotes mean levels of F-actin-treated cells. Data are shown as the ratio of control, untreated cells. Values represent the mean &#177; S.E. for 3&#8211;4 experiments per group. <sup>*</sup>, <italic>p</italic> &lt; 0.05 compared with the appropriate labeled control for each treatment. <italic>Scale bars</italic>, 10 &#956;<sc>m</sc>. <italic>PIP<sub>3</sub></italic>, PtdIns(3,4,5)P<sub>3</sub>.</p></caption><graphic xlink:href="zbc0190972430002"/></fig>
FIGURE 2.Effect of PTEN phosphorylation mutants on PtdIns(3,4,5)P3 and F-actin levels in N29/4 cells. Wild-type PTEN and T366A PTEN (A) and S370A PTEN (B) were overexpressed in N29/4 cells (upper panels, Cy3 secondary antibody on cells treated with monoclonal PTEN antibody) and F-actin visualized with Alexa 488-phalloidin (lower panels) with and without stimulation by 10 nm leptin. Note that untransfected cells in the leptin (L)-treated group are not easily visible in the right lower panels due to leptin-mediated F-actin depolymerization. Bar graphs showing mean levels of F-actin after treatment of N29/4 cells +/- overexpression of PTEN or T366A PTEN (A) or S370A PTEN (B) with 10 nm leptin. Data are shown as a ratio of control, untreated cells. C, PtdIns(3,4,5)P3 levels in N29/4 cells transfected with T366D PTEN or S370D PTEN were investigated using a PtdIns(3,4,5)P3 antibody. The bar graph shows mean levels of PtdIns(3,4,5)P3 (as a ratio of control) in N29/4 cells after treatment with these PTEN phosphorylation mutants. D and E, F-actin levels were visualized (lower panels) in N29/4 cells transfected (upper panels) with T366D PTEN (D) or S370D PTEN (E) in the absence (left) and presence (right) of 10 mum LY294002 (LY, D) or 10 nm leptin (E). The bar graphs show mean levels of F-actin after treatment of N29/4 cells overexpressing T366D PTEN (D) or S370D PTEN (E). Data are shown as a ratio of control, untreated cells. F, cellular F-actin levels in the absence or presence of 10 nm leptin and in cells pretreated with 2 mum CT99021 alone (CT) or in combination with 10 mum DMAT (D) before leptin challenge. Note that F-actin is visualized in this series of experiments with rhodamine-conjugated phalloidin. The bar graph denotes mean levels of F-actin-treated cells. Data are shown as the ratio of control, untreated cells. Values represent the mean +/- S.E. for 3-4 experiments per group. *, p < 0.05 compared with the appropriate labeled control for each treatment. Scale bars, 10 mum. PIP3, PtdIns(3,4,5)P3.
###end p 24
###begin p 25
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of PTEN phosphorylation mutants on PtdIns(3,4,5)P<sub>3</sub> and F-actin levels in N29/4 cells.</bold>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 181 193 181 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 316 328 316 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 366 367 366 367 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 468 486 468 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right lower panels</italic>
###xml 536 546 536 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bar graphs</italic>
###xml 651 652 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 669 670 667 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 681 682 679 680 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 746 747 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 763 764 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 869 870 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 885 894 883 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 930 931 928 929 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1028 1029 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1034 1035 1032 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1069 1081 1067 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panels</italic>
###xml 1111 1123 1109 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper panels</italic>
###xml 1142 1143 1140 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1160 1161 1158 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1179 1183 1177 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 1199 1204 1197 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 1214 1215 1211 1212 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1226 1228 1223 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LY</italic>
###xml 1230 1231 1227 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1240 1241 1237 1238 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1250 1251 1247 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1258 1268 1255 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 1355 1356 1352 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1373 1374 1370 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1432 1433 1429 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1493 1494 1490 1491 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1535 1536 1531 1532 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1552 1554 1548 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 1584 1585 1579 1580 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1592 1593 1587 1588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1724 1733 1719 1728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 1903 1904 1896 1897 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 1906 1907 1899 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1981 1991 1974 1984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bars</italic>
###xml 1998 1999 1990 1991 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2004 2005 1996 1997 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2001 2005 1993 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PIP<sub>3</sub></italic>
###xml 2021 2022 2013 2014 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Effect of PTEN phosphorylation mutants on PtdIns(3,4,5)P3 and F-actin levels in N29/4 cells. Wild-type PTEN and T366A PTEN (A) and S370A PTEN (B) were overexpressed in N29/4 cells (upper panels, Cy3 secondary antibody on cells treated with monoclonal PTEN antibody) and F-actin visualized with Alexa 488-phalloidin (lower panels) with and without stimulation by 10 nm leptin. Note that untransfected cells in the leptin (L)-treated group are not easily visible in the right lower panels due to leptin-mediated F-actin depolymerization. Bar graphs showing mean levels of F-actin after treatment of N29/4 cells +/- overexpression of PTEN or T366A PTEN (A) or S370A PTEN (B) with 10 nm leptin. Data are shown as a ratio of control, untreated cells. C, PtdIns(3,4,5)P3 levels in N29/4 cells transfected with T366D PTEN or S370D PTEN were investigated using a PtdIns(3,4,5)P3 antibody. The bar graph shows mean levels of PtdIns(3,4,5)P3 (as a ratio of control) in N29/4 cells after treatment with these PTEN phosphorylation mutants. D and E, F-actin levels were visualized (lower panels) in N29/4 cells transfected (upper panels) with T366D PTEN (D) or S370D PTEN (E) in the absence (left) and presence (right) of 10 mum LY294002 (LY, D) or 10 nm leptin (E). The bar graphs show mean levels of F-actin after treatment of N29/4 cells overexpressing T366D PTEN (D) or S370D PTEN (E). Data are shown as a ratio of control, untreated cells. F, cellular F-actin levels in the absence or presence of 10 nm leptin and in cells pretreated with 2 mum CT99021 alone (CT) or in combination with 10 mum DMAT (D) before leptin challenge. Note that F-actin is visualized in this series of experiments with rhodamine-conjugated phalloidin. The bar graph denotes mean levels of F-actin-treated cells. Data are shown as the ratio of control, untreated cells. Values represent the mean +/- S.E. for 3-4 experiments per group. *, p < 0.05 compared with the appropriate labeled control for each treatment. Scale bars, 10 mum. PIP3, PtdIns(3,4,5)P3.
###end p 25
###begin p 26
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 263 264 262 263 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 298 299 296 297 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 460 461 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 454 461 452 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>F</italic></xref>
###xml 664 665 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 658 665 656 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2<italic>F</italic></xref>
The dependence of F-actin depolymerization by leptin on the phosphorylation status of the cluster (12) and Thr-366 sites led us to explore whether this action of leptin was sensitive to CK2 and/or GSK3 inhibition. The presence of the GSK3 inhibitor, CT99021 (2 mum) or the CK2 inhibitor DMAT (10 mum) alone had no effect on F-actin (data not shown). Leptin decreased the mean F-actin level, and in the presence of CT99021 this was significantly reduced (Fig. 2F). The combined presence of CT99021 and DMAT inhibited F-actin depolymerization by leptin significantly more than CT99021 alone but did not completely occlude leptin from affecting F-actin levels (Fig. 2F). Nevertheless, the presence of the GSK3 and CK2 inhibitors at concentrations that significantly reduced PTEN phosphorylation also significantly reduced the ability of leptin to depolymerize F-actin.
###end p 26
###begin p 27
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phosphorylation of PTEN in</italic>
###xml 43 46 40 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 31 57 28 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-Cells and K<sub>ATP</sub> Activation</italic>
###xml 95 98 92 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 324 326 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 468 471 462 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 722 723 707 708 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 872 873 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 878 879 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 864 879 847 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A</italic> and <italic>B</italic></xref>
###xml 895 896 878 879 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 996 999 979 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;C</italic>
###xml 988 999 971 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A&#8211;C</italic></xref>
###xml 1030 1031 1012 1013 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1145 1146 1126 1127 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1197 1198 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1191 1198 1172 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
Phosphorylation of PTEN in beta-Cells and KATP Activation-It was previously demonstrated that KATP channel opening and hyperpolarization of mouse pancreatic beta-cells by leptin could be inhibited by the lipid phosphatase dead G129E PTEN mutant and mimicked by the dual lipid and protein phosphatase dead C124S PTEN mutant (12). This is consistent with inhibition of PTEN lipid and protein phosphatase activity for the successful transmission of the leptin signal to KATP channels in beta-cells. As leptin has not been shown to alter p-PTEN status in beta-cells, we used MIN6 beta-cells to explore this action of leptin. Although the effects of leptin on p-PTEN were not as robust as observed for N29/4 cells, leptin (10 nm) rapidly (</=1 min) increased phosphorylation of the cluster site, Ser-370 and Thr-366, actions sustained for at least 30 min in each case (Fig. 3, A and B). Insulin (10 nm) had no effect on PTEN phosphorylation levels at any of these sites over this time period (Fig. 3, A-C). The CK2 inhibitor DMAT (2 mum) inhibited leptin-mediated PTEN phosphorylation at Ser-370 and Thr-366, whereas the GSK3 inhibitor CT99021 (10 mum) inhibited phosphorylation at Thr-366 only (Fig. 3D).
###end p 27
###begin p 28
###xml 70 73 70 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 253 256 253 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 536 537 530 531 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 608 609 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 675 676 667 668 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 735 736 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 729 736 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 775 776 765 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 783 784 773 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 847 848 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 855 856 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 904 905 891 892 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 938 939 925 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 932 939 919 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 1051 1052 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1059 1060 1042 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1133 1134 1114 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1141 1142 1122 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1293 1296 1271 1274 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1314 1316 1292 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 1318 1320 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 1322 1324 1300 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref30">30</xref>
###xml 1354 1355 1331 1332 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1482 1483 1457 1458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1576 1577 1551 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1625 1626 1598 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1638 1639 1611 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1632 1639 1605 1612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1677 1678 1650 1651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1843 1844 1813 1814 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1837 1844 1807 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1852 1855 1822 1825 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1951 1952 1918 1919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1945 1952 1912 1919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1976 1979 1943 1946 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 2008 2009 1974 1975 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2064 2065 2028 2029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2153 2154 2113 2114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2160 2161 2120 2121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2184 2185 2143 2144 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2313 2314 2267 2268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2307 2314 2261 2268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 2445 2446 2397 2398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2452 2453 2404 2405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2667 2668 2616 2617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 2661 2668 2610 2617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 2899 2902 2842 2845 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 2987 2989 2930 2932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 2991 2993 2934 2936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 3012 3014 2955 2957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
###xml 3046 3049 2989 2992 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 3084 3085 3026 3027 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3108 3109 3049 3050 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3152 3153 3093 3094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3291 3292 3225 3226 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3384 3385 3313 3314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3429 3430 3356 3357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3464 3465 3391 3392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3504 3505 3431 3432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 3510 3511 3437 3438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 3496 3511 3423 3438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>D</italic> and <italic>E</italic></xref>
###xml 3652 3653 3579 3580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 3658 3659 3585 3586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 3644 3659 3571 3586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>D</italic> and <italic>E</italic></xref>
###xml 3679 3680 3605 3606 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3781 3784 3704 3707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C&#8211;E</italic>
###xml 3773 3784 3696 3707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, <italic>C&#8211;E</italic></xref>
###xml 3816 3817 3737 3738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3823 3824 3744 3745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3866 3867 3785 3786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3873 3874 3792 3793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3922 3923 3839 3840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3929 3930 3846 3847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 4039 4040 3953 3954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
Consequently, we predicted that the F-actin reduction and opening of KATP channels by leptin (12, 13) would be susceptible to inhibition of CK2 and GSK3. Therefore, we examined the ability of leptin to hyperpolarize the membrane potential and activate KATP currents in whole-cell current and voltage clamp recordings, respectively, from mouse primary cultured pancreatic beta-cells in the absence and presence of DMAT and various GSK3 inhibitors. In control experiments beta-cells were dialyzed with an electrode solution containing 3 mm ATP, which resulted in a mean membrane potential of -41.8 +/- 1.5 mV (n = 22) under current clamp conditions. Application of leptin (10 nm) resulted in a slowly developing hyperpolarization (Fig. 4A) to a mean value of -69.4 +/- 1.6 mV (n = 22, p < 0.05), which was reversibly inhibited (to -34.5 +/- 1.9 mV; n = 17, p < 0.05) by the sulfonylurea tolbutamide (100 mum). Voltage clamp analysis (Fig. 4A) showed that leptin increased the mean cell slope conductance from 0.73 +/- 0.11 to 1.62 +/- 0.22 nanosiemens (n = 19; p < 0.05), an action reduced by tolbutamide to 0.42 +/- 0.04 nanosiemens (n = 14; p < 0.05), indicating that the increase in current responsible for the augmented slope conductance and beta-cell hyperpolarization by leptin is due to KATP channel opening (14, 15, 30). The presence of DMAT (10 mum) in the electrode solution (and, therefore, cell interior) resulted in a mean resting membrane potential of -44.8 +/- 3.4 mV (p > 0.05 compared with control). Subsequent addition of leptin caused a small, insignificant (p > 0.05) hyperpolarization to -52.4 +/- 8.4 mV (n = 5; Fig. 4B), which was significantly different (p < 0.05) from the control leptin response. Voltage clamp analysis showed that DMAT also prevented leptin from increasing the beta-cell mean slope conductance (Fig. 4B). The KATP channels were operational in the presence of DMAT as beta-cells were readily responsive (Fig. 4B) to the direct-acting KATP activator, diazoxide (200 mum), which caused hyperpolarization to -75.2 +/- 1.7 mV (p < 0.05) and increased slope conductance from 0.82 +/- 0.07 to 3.1 +/- 0.8 nanosiemens (n = 5; p < 0.05). CT99021 (2 mum), in the electrode solution, resulted in a mean beta-cell membrane potential of -41.5 +/- 3.3 mV. Application of leptin (Fig. 4C) caused hyperpolarization to -51.5 +/- 4.1 mV, which although less than the control leptin response, was significantly different (n = 5, p < 0.05) from the mean resting potential before leptin challenge. However, voltage clamp analysis showed that in the presence of CT99021 leptin did not significantly increase the beta-cell slope conductance (Fig. 4C). As a small, but significant hyperpolarization of beta-cells was elicited by leptin in the presence of CT99021, we decided to confirm that GSK3 inhibition does occlude leptin-mediated beta-cell hyperpolarization and increase in KATP current. Consequently, we examined the effects of the GSK3 inhibitors, AR-A0144-18 (28, 31) and kenpaullone (29) on leptin-induced opening of KATP. The presence of AR-A0144-18 (2 mum) or kenpaullone (10 mum) in the electrode solution did not alter (p < 0.05) beta-cell membrane potential (-40.4 +/- 1.6 mV and -35.2 +/- 2.1 mV, respectively) compared with control recordings. Leptin (10 nm) caused a small hyperpolarization of the beta-cells for both AR-A014418 (to -51.8 +/- 6.4; n = 5) and kenpaullone (to -45.5 +/- 4.6 mV; n = 6), which was not significant (p > 0.05) for either inhibitor (Fig. 4, D and E). Voltage clamp analysis confirmed that the presence of either GSK3 inhibitor prevented an increase in slope conductance by leptin (Fig. 4, D and E). Diazoxide (200 mum), in contrast, reversibly hyperpolarized beta-cells in the presence of each GSK3 inhibitor (Fig. 4, C-E, CT99021, to -73.0 +/- 2.2 mV (n = 5; p < 0.05), AR-A014418 to -72.4 +/- 4.1 mV (n = 5, p < 0.05), and kenpaullone, to -72.3 +/- 2.4 mV (n = 6, p < 0.05) and significantly increased the mean slope conductance to values comparable for control beta-cells (p < 0.05).
###end p 28
###begin p 29
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 77 9 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin increases PTEN phosphorylation in MIN6 pancreatic &#946;-cells.</bold>
###xml 77 78 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 230 231 227 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 246 247 243 244 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 291 292 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 298 307 295 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 464 475 461 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 477 478 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 497 506 494 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 508 509 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 529 530 526 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 532 533 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 542 548 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 558 559 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 574 575 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 577 586 574 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 678 679 675 676 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 706 707 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 709 719 706 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 832 833 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 866 867 863 864 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 891 892 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 916 917 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 918 919 915 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 934 935 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 936 938 933 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 940 941 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 957 958 954 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 960 961 957 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 9 969 9 966 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30"><bold>Leptin increases PTEN phosphorylation in MIN6 pancreatic &#946;-cells.</bold><italic>A</italic>, phosphorylated PTEN levels in MIN6 cells using the phospho-specific PTEN antibodies indicated (cluster site, Ser-370 and Thr-366), in response to 10 n<sc>m</sc> leptin or 10 n<sc>m</sc> insulin for the indicated times (minutes). <italic>B</italic>, the <italic>bar graph</italic> shows mean normalized levels of phosphorylated PTEN at the cluster phosphorylation site (380/2/3) for untreated cells and for cells stimulated with leptin (<italic>filled bars</italic>; <italic>n</italic> = 6) and insulin (<italic>open bars</italic>; <italic>n</italic> = 8) up to 30 min (<sup>*</sup>, <italic>p</italic> &lt; 0.05, <italic>versus</italic> control (<italic>C</italic>) or insulin). <italic>C</italic>, <italic>bar graph</italic> shows the mean normalized levels of phosphorylated Thr-366 PTEN after stimulation with 10 n<sc>m</sc> insulin for 5 and 30 min. <italic>D</italic>, <italic>bar graphs</italic> showing mean normalized levels of phosphorylated Thr-366 PTEN and Ser-370 PTEN under non-stimulated conditions (<italic>C</italic>) and after stimulation with 10 n<sc>m</sc> leptin in the absence (<italic>L</italic>) and presence of DMAT (<italic>L</italic>+<italic>D</italic>) and CT99021 (<italic>L</italic>+<italic>CT</italic>; <italic>n</italic> = 7 for each). <sup>*</sup>, <italic>p</italic> &lt; 0.05.</p>
###xml 9 969 9 966 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="30"><bold>Leptin increases PTEN phosphorylation in MIN6 pancreatic &#946;-cells.</bold><italic>A</italic>, phosphorylated PTEN levels in MIN6 cells using the phospho-specific PTEN antibodies indicated (cluster site, Ser-370 and Thr-366), in response to 10 n<sc>m</sc> leptin or 10 n<sc>m</sc> insulin for the indicated times (minutes). <italic>B</italic>, the <italic>bar graph</italic> shows mean normalized levels of phosphorylated PTEN at the cluster phosphorylation site (380/2/3) for untreated cells and for cells stimulated with leptin (<italic>filled bars</italic>; <italic>n</italic> = 6) and insulin (<italic>open bars</italic>; <italic>n</italic> = 8) up to 30 min (<sup>*</sup>, <italic>p</italic> &lt; 0.05, <italic>versus</italic> control (<italic>C</italic>) or insulin). <italic>C</italic>, <italic>bar graph</italic> shows the mean normalized levels of phosphorylated Thr-366 PTEN after stimulation with 10 n<sc>m</sc> insulin for 5 and 30 min. <italic>D</italic>, <italic>bar graphs</italic> showing mean normalized levels of phosphorylated Thr-366 PTEN and Ser-370 PTEN under non-stimulated conditions (<italic>C</italic>) and after stimulation with 10 n<sc>m</sc> leptin in the absence (<italic>L</italic>) and presence of DMAT (<italic>L</italic>+<italic>D</italic>) and CT99021 (<italic>L</italic>+<italic>CT</italic>; <italic>n</italic> = 7 for each). <sup>*</sup>, <italic>p</italic> &lt; 0.05.</p></caption>
###xml 969 969 966 966 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972430003"/>
###xml 0 969 0 966 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="30"><bold>Leptin increases PTEN phosphorylation in MIN6 pancreatic &#946;-cells.</bold><italic>A</italic>, phosphorylated PTEN levels in MIN6 cells using the phospho-specific PTEN antibodies indicated (cluster site, Ser-370 and Thr-366), in response to 10 n<sc>m</sc> leptin or 10 n<sc>m</sc> insulin for the indicated times (minutes). <italic>B</italic>, the <italic>bar graph</italic> shows mean normalized levels of phosphorylated PTEN at the cluster phosphorylation site (380/2/3) for untreated cells and for cells stimulated with leptin (<italic>filled bars</italic>; <italic>n</italic> = 6) and insulin (<italic>open bars</italic>; <italic>n</italic> = 8) up to 30 min (<sup>*</sup>, <italic>p</italic> &lt; 0.05, <italic>versus</italic> control (<italic>C</italic>) or insulin). <italic>C</italic>, <italic>bar graph</italic> shows the mean normalized levels of phosphorylated Thr-366 PTEN after stimulation with 10 n<sc>m</sc> insulin for 5 and 30 min. <italic>D</italic>, <italic>bar graphs</italic> showing mean normalized levels of phosphorylated Thr-366 PTEN and Ser-370 PTEN under non-stimulated conditions (<italic>C</italic>) and after stimulation with 10 n<sc>m</sc> leptin in the absence (<italic>L</italic>) and presence of DMAT (<italic>L</italic>+<italic>D</italic>) and CT99021 (<italic>L</italic>+<italic>CT</italic>; <italic>n</italic> = 7 for each). <sup>*</sup>, <italic>p</italic> &lt; 0.05.</p></caption><graphic xlink:href="zbc0190972430003"/></fig>
FIGURE 3.Leptin increases PTEN phosphorylation in MIN6 pancreatic beta-cells.A, phosphorylated PTEN levels in MIN6 cells using the phospho-specific PTEN antibodies indicated (cluster site, Ser-370 and Thr-366), in response to 10 nm leptin or 10 nm insulin for the indicated times (minutes). B, the bar graph shows mean normalized levels of phosphorylated PTEN at the cluster phosphorylation site (380/2/3) for untreated cells and for cells stimulated with leptin (filled bars; n = 6) and insulin (open bars; n = 8) up to 30 min (*, p < 0.05, versus control (C) or insulin). C, bar graph shows the mean normalized levels of phosphorylated Thr-366 PTEN after stimulation with 10 nm insulin for 5 and 30 min. D, bar graphs showing mean normalized levels of phosphorylated Thr-366 PTEN and Ser-370 PTEN under non-stimulated conditions (C) and after stimulation with 10 nm leptin in the absence (L) and presence of DMAT (L+D) and CT99021 (L+CT; n = 7 for each). *, p < 0.05.
###end p 29
###begin p 30
###xml 0 68 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin increases PTEN phosphorylation in MIN6 pancreatic &#946;-cells.</bold>
###xml 68 69 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 221 222 218 219 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 237 238 234 235 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 282 283 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 289 298 286 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 455 466 452 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 468 469 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 488 497 485 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 499 500 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 520 521 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 523 524 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 533 539 530 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 549 550 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 565 566 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 568 577 565 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 669 670 666 667 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 697 698 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 700 710 697 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 823 824 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 857 858 854 855 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 882 883 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 907 908 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 909 910 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 925 926 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">L</italic>
###xml 927 929 924 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT</italic>
###xml 931 932 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 948 949 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 951 952 948 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Leptin increases PTEN phosphorylation in MIN6 pancreatic beta-cells.A, phosphorylated PTEN levels in MIN6 cells using the phospho-specific PTEN antibodies indicated (cluster site, Ser-370 and Thr-366), in response to 10 nm leptin or 10 nm insulin for the indicated times (minutes). B, the bar graph shows mean normalized levels of phosphorylated PTEN at the cluster phosphorylation site (380/2/3) for untreated cells and for cells stimulated with leptin (filled bars; n = 6) and insulin (open bars; n = 8) up to 30 min (*, p < 0.05, versus control (C) or insulin). C, bar graph shows the mean normalized levels of phosphorylated Thr-366 PTEN after stimulation with 10 nm insulin for 5 and 30 min. D, bar graphs showing mean normalized levels of phosphorylated Thr-366 PTEN and Ser-370 PTEN under non-stimulated conditions (C) and after stimulation with 10 nm leptin in the absence (L) and presence of DMAT (L+D) and CT99021 (L+CT; n = 7 for each). *, p < 0.05.
###end p 30
###begin p 31
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 23 24 23 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 9 132 9 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activation of <italic>K</italic><sub>ATP</sub> channels in mouse pancreatic &#946;-cells by leptin is occluded by the presence of CK2 or GSK3 inhibitors.</bold>
###xml 266 267 260 261 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 396 397 378 379 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 413 417 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tolb</italic>
###xml 425 426 406 407 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 443 446 424 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dzx</italic>
###xml 454 455 434 435 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 508 511 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 514 518 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cont</italic>
###xml 613 614 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 637 638 613 614 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 645 646 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 653 654 628 629 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 664 665 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 673 674 647 648 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 688 689 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 700 701 673 674 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 715 716 688 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 781 791 754 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 799 804 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 813 818 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trace</italic>
###xml 967 968 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1201 1202 1173 1174 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1309 1310 1281 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 1312 1313 1284 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 9 1344 9 1316 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>Activation of <italic>K</italic><sub>ATP</sub> channels in mouse pancreatic &#946;-cells by leptin is occluded by the presence of CK2 or GSK3 inhibitors.</bold> Representative whole-cell current clamp recordings from a mouse cultured &#946;-cell dialyzed with an electrode solution containing 3 m<sc>m</sc> ATP. In this and subsequent panels the trace begins &#8764;2 min after obtaining the recording configuration. Leptin (10 n<sc>m</sc>), tolbutamide (<italic>Tolb</italic>, 100 &#956;<sc>m</sc>), or diazoxide (<italic>Dzx</italic>, 200 &#956;<sc>m</sc>) were applied for the time indicated on each trace (<italic>A&#8211;E</italic>). <italic>Cont</italic>, control. The action of leptin on &#946;-cell membrane potential was determined in the absence (<italic>A</italic>) and presence of 10 &#956;<sc>m</sc> DMAT (<italic>B</italic>), 2 &#956;<sc>m</sc> CT99021 (<italic>C</italic>), 10 &#956;<sc>m</sc> kenpaullone (<italic>D</italic>), and 2 &#956;<sc>m</sc> AR-A0144&#8211;18 (<italic>E</italic>) added to the electrode solution and, hence, cell interior. The <italic>bar graphs</italic> to the <italic>right</italic> of each <italic>trace</italic> denote the mean slope conductance, determined from voltage clamp current-voltage relations in the absence and presence of leptin. In control cells (<italic>A</italic>) the hyperpolarization and increased slope conductance induced by leptin are inhibited by the presence of tolbutamide. For drug-treated cells leptin has no effect on mean cell conductance, although in each case application of 200 &#956;<sc>m</sc> diazoxide hyperpolarizes the cells, which is associated with a significant increase in slope conductance. <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control.</p>
###xml 9 1344 9 1316 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>Activation of <italic>K</italic><sub>ATP</sub> channels in mouse pancreatic &#946;-cells by leptin is occluded by the presence of CK2 or GSK3 inhibitors.</bold> Representative whole-cell current clamp recordings from a mouse cultured &#946;-cell dialyzed with an electrode solution containing 3 m<sc>m</sc> ATP. In this and subsequent panels the trace begins &#8764;2 min after obtaining the recording configuration. Leptin (10 n<sc>m</sc>), tolbutamide (<italic>Tolb</italic>, 100 &#956;<sc>m</sc>), or diazoxide (<italic>Dzx</italic>, 200 &#956;<sc>m</sc>) were applied for the time indicated on each trace (<italic>A&#8211;E</italic>). <italic>Cont</italic>, control. The action of leptin on &#946;-cell membrane potential was determined in the absence (<italic>A</italic>) and presence of 10 &#956;<sc>m</sc> DMAT (<italic>B</italic>), 2 &#956;<sc>m</sc> CT99021 (<italic>C</italic>), 10 &#956;<sc>m</sc> kenpaullone (<italic>D</italic>), and 2 &#956;<sc>m</sc> AR-A0144&#8211;18 (<italic>E</italic>) added to the electrode solution and, hence, cell interior. The <italic>bar graphs</italic> to the <italic>right</italic> of each <italic>trace</italic> denote the mean slope conductance, determined from voltage clamp current-voltage relations in the absence and presence of leptin. In control cells (<italic>A</italic>) the hyperpolarization and increased slope conductance induced by leptin are inhibited by the presence of tolbutamide. For drug-treated cells leptin has no effect on mean cell conductance, although in each case application of 200 &#956;<sc>m</sc> diazoxide hyperpolarizes the cells, which is associated with a significant increase in slope conductance. <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control.</p></caption>
###xml 1344 1344 1316 1316 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972430004"/>
###xml 0 1344 0 1316 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="32"><bold>Activation of <italic>K</italic><sub>ATP</sub> channels in mouse pancreatic &#946;-cells by leptin is occluded by the presence of CK2 or GSK3 inhibitors.</bold> Representative whole-cell current clamp recordings from a mouse cultured &#946;-cell dialyzed with an electrode solution containing 3 m<sc>m</sc> ATP. In this and subsequent panels the trace begins &#8764;2 min after obtaining the recording configuration. Leptin (10 n<sc>m</sc>), tolbutamide (<italic>Tolb</italic>, 100 &#956;<sc>m</sc>), or diazoxide (<italic>Dzx</italic>, 200 &#956;<sc>m</sc>) were applied for the time indicated on each trace (<italic>A&#8211;E</italic>). <italic>Cont</italic>, control. The action of leptin on &#946;-cell membrane potential was determined in the absence (<italic>A</italic>) and presence of 10 &#956;<sc>m</sc> DMAT (<italic>B</italic>), 2 &#956;<sc>m</sc> CT99021 (<italic>C</italic>), 10 &#956;<sc>m</sc> kenpaullone (<italic>D</italic>), and 2 &#956;<sc>m</sc> AR-A0144&#8211;18 (<italic>E</italic>) added to the electrode solution and, hence, cell interior. The <italic>bar graphs</italic> to the <italic>right</italic> of each <italic>trace</italic> denote the mean slope conductance, determined from voltage clamp current-voltage relations in the absence and presence of leptin. In control cells (<italic>A</italic>) the hyperpolarization and increased slope conductance induced by leptin are inhibited by the presence of tolbutamide. For drug-treated cells leptin has no effect on mean cell conductance, although in each case application of 200 &#956;<sc>m</sc> diazoxide hyperpolarizes the cells, which is associated with a significant increase in slope conductance. <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control.</p></caption><graphic xlink:href="zbc0190972430004"/></fig>
###xml 40 45 <span type="species:ncbi:10090">mouse</span>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
FIGURE 4.Activation of KATP channels in mouse pancreatic beta-cells by leptin is occluded by the presence of CK2 or GSK3 inhibitors. Representative whole-cell current clamp recordings from a mouse cultured beta-cell dialyzed with an electrode solution containing 3 mm ATP. In this and subsequent panels the trace begins approximately2 min after obtaining the recording configuration. Leptin (10 nm), tolbutamide (Tolb, 100 mum), or diazoxide (Dzx, 200 mum) were applied for the time indicated on each trace (A-E). Cont, control. The action of leptin on beta-cell membrane potential was determined in the absence (A) and presence of 10 mum DMAT (B), 2 mum CT99021 (C), 10 mum kenpaullone (D), and 2 mum AR-A0144-18 (E) added to the electrode solution and, hence, cell interior. The bar graphs to the right of each trace denote the mean slope conductance, determined from voltage clamp current-voltage relations in the absence and presence of leptin. In control cells (A) the hyperpolarization and increased slope conductance induced by leptin are inhibited by the presence of tolbutamide. For drug-treated cells leptin has no effect on mean cell conductance, although in each case application of 200 mum diazoxide hyperpolarizes the cells, which is associated with a significant increase in slope conductance. *, p < 0.05, compared with control.
###end p 31
###begin p 32
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 15 18 15 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 0 123 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activation of <italic>K</italic><sub>ATP</sub> channels in mouse pancreatic &#946;-cells by leptin is occluded by the presence of CK2 or GSK3 inhibitors.</bold>
###xml 257 258 251 252 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 387 388 369 370 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 404 408 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tolb</italic>
###xml 416 417 397 398 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 434 437 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dzx</italic>
###xml 445 446 425 426 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 499 502 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 505 509 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cont</italic>
###xml 604 605 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 628 629 604 605 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 636 637 612 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 644 645 619 620 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 655 656 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 664 665 638 639 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 679 680 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 691 692 664 665 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 706 707 679 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 772 782 745 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs</italic>
###xml 790 795 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 804 809 777 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trace</italic>
###xml 958 959 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1192 1193 1164 1165 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1300 1301 1272 1273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 1303 1304 1275 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
Activation of KATP channels in mouse pancreatic beta-cells by leptin is occluded by the presence of CK2 or GSK3 inhibitors. Representative whole-cell current clamp recordings from a mouse cultured beta-cell dialyzed with an electrode solution containing 3 mm ATP. In this and subsequent panels the trace begins approximately2 min after obtaining the recording configuration. Leptin (10 nm), tolbutamide (Tolb, 100 mum), or diazoxide (Dzx, 200 mum) were applied for the time indicated on each trace (A-E). Cont, control. The action of leptin on beta-cell membrane potential was determined in the absence (A) and presence of 10 mum DMAT (B), 2 mum CT99021 (C), 10 mum kenpaullone (D), and 2 mum AR-A0144-18 (E) added to the electrode solution and, hence, cell interior. The bar graphs to the right of each trace denote the mean slope conductance, determined from voltage clamp current-voltage relations in the absence and presence of leptin. In control cells (A) the hyperpolarization and increased slope conductance induced by leptin are inhibited by the presence of tolbutamide. For drug-treated cells leptin has no effect on mean cell conductance, although in each case application of 200 mum diazoxide hyperpolarizes the cells, which is associated with a significant increase in slope conductance. *, p < 0.05, compared with control.
###end p 32
###begin p 33
###xml 0 43 0 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phosphorylation and Kinase Activity of GSK3</italic>
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 266 267 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 302 305 302 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 535 538 535 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 960 961 960 961 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1025 1026 1025 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1150 1152 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 606 609 <span type="species:ncbi:10116">rat</span>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
###xml 781 786 <span type="species:ncbi:10090">mouse</span>
Phosphorylation and Kinase Activity of GSK3-These results taken together with those of Ning et al. (12) indicate that leptin inhibits PTEN phosphatase activity via phosphorylation at multiple sites on the C terminus of PTEN, which results in increased PtdIns(3,4,5)P3 levels, actin restructuring, and KATP activation. These events appear to be mediated through CK2- and GSK3-dependent mechanisms. However, the dependence on PTEN Thr-366 phosphorylation on GSK3 activity and consequent influence on downstream signaling events such as KATP channel regulation gives rise to a quandary. Leptin stimulation of rat arcuate increases PKB phosphorylation with subsequent GSK3 phosphorylation at Ser-9/Ser-21 (13), actions also reported for leptin on mouse skeletal muscle cells (32, 33), mouse cortical neurons (34), and MCF-7 breast cancer cells (35). These latter actions of leptin replicate those of insulin, which increases PI3K activity and raises PtdIns(3,4,5)P3 levels with subsequent increased PKB and GSK3 phosphorylation (5). Importantly, the phosphorylation of GSK3 at these serine residues by PKB is associated with reduced kinase activity (36, 37).
###end p 33
###begin p 34
###xml 168 169 168 169 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref33">33</xref>
###xml 428 429 428 429 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 629 630 626 627 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 649 650 646 647 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 690 691 687 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 696 697 693 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 682 697 679 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, <italic>C</italic> and <italic>D</italic></xref>
###xml 862 865 859 862 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 1136 1138 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 1140 1142 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 1247 1249 1237 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 1265 1266 1255 1256 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1356 1357 1346 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1350 1357 1340 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 1385 1386 1372 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1379 1386 1366 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1414 1415 1401 1402 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1491 1492 1478 1479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1485 1492 1472 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1511 1512 1498 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1505 1512 1492 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>D</italic></xref>
###xml 1869 1870 1856 1857 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1889 1890 1876 1877 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2168 2169 2155 2156 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2244 2245 2231 2232 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2367 2368 2351 2352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 2361 2368 2345 2352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>E</italic></xref>
###xml 371 374 <span type="species:ncbi:10116">rat</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
This outcome is inconsistent with the requirement for active GSK3 causing phosphorylation of PTEN Thr-366 allowing subsequent downstream signaling. Indeed, leptin (10 nm) increases the phosphorylation of PKB (Ser-473) and GSK3 (Ser-9/Ser-21) in N29/4 hypothalamic cells (Fig. 5A), although this is not well sustained in the hypothalamic cells, as previously reported for rat arcuate (13) and mouse muscle (32, 33). Insulin (10 nm) induced a sustained rise in PKB (Ser-473) and GSK3 (Ser-9/Ser-21) phosphorylation in N29/4 cells (Fig. 5B). Similar results were obtained for MIN6 beta-cells, although in this case both leptin (10 nm) and insulin (10 nm) produced sustained increases (Fig. 5, C and D) in the levels of phosphorylated PKB (Ser-473) and GSK3 (Ser-9/Ser-21). These results are ostensibly inconsistent with the view that leptin signaling to actin and KATP channels requires GSK3-dependent phosphorylation and inhibition of PTEN activity. However, GSK3 also has a tyrosine residue in the activation loop of the enzyme (Tyr-216 in GSK3beta and Tyr-279 in GSK3alpha), the phosphorylation of which is important for GSK3 activity (38, 39). Most studies conclude that this site is not physiologically regulated by growth factors or cytokines (40). Insulin (10 nm) did not affect GSK3 Tyr-216/Tyr-279 phosphorylation levels in either N29/4 cells (Fig. 6A) or MIN6 beta-cells (Fig. 6C). In contrast, leptin (10 nm) rapidly increased GSK3 phosphorylation at Tyr-216/Tyr-279 in N29/4 (Fig. 6B), and MIN6 (Fig. 6D) cells, which was sustained for at least 1 h. Thus, in contrast to insulin, which increases phosphorylation of GSK3 serine sites only (consistent with kinase inhibition), leptin increases the phosphorylation level of both serine and tyrosine sites on GSK3. To define the outcome of this dual phosphorylation of GSK3, we examined the effects of leptin (10 nm) and insulin (50 nm) on GSK3 activity in N29/4 cells. Stimulation of N29/4 cells by insulin for 30 min results in a substantial inhibition of GSK3 activity, as expected from increased PKB activity causing GSK3 Ser-9/Ser-21 phosphorylation. In contrast, stimulation of N29/4 cells with leptin (10 nm) for 30 min, a time when PTEN phosphorylation is increased, PtdIns(3,4,5)P3 levels are high, F-actin is depolymerized, and beta-cells are hyperpolarized, results in maintained GSK3 activity (Fig. 6E). This outcome is consistent with the finding that, although both hormones increase GSK3 Ser-9/Ser-21 phosphorylation levels, leptin, but not insulin, also increases GSK3 Tyr-216/Tyr-279 phosphorylation.
###end p 34
###begin title 35
DISCUSSION
###end title 35
###begin p 36
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 475 477 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 810 812 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1095 1096 1092 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1187 1195 1184 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1279 1281 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 1349 1351 1346 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1402 1403 1399 1400 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1461 1467 1458 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 1673 1679 1670 1676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 1739 1740 1736 1737 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1915 1917 1912 1914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 2120 2126 2117 2123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 2180 2181 2177 2178 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2440 2442 2437 2439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 2506 2507 2503 2504 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2767 2768 2764 2765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2860 2862 2857 2859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 3386 3387 3383 3384 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 3425 3431 3422 3428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
Leptin phosphorylation of PTEN at the cluster site is CK2-dependent and leads to inhibition of PTEN phosphatase activity with a consequent increase in PtdIns(3,4,5)P3 levels in N29/4 cells (12). Here, we show that leptin increases PTEN phosphorylation at three further sites, Thr-366, Ser-370, and Ser-385 in N29/4 cells. We also show that leptin increases p-PTEN at the cluster site, Thr-366 and Ser-370, in MIN6 pancreatic beta-cells. As demonstrated for the cluster site (12), phosphorylation of PTEN in N29/4 cells at Thr-366 and Ser-370 is important for transfer of the leptin signal downstream to cause F-actin depolymerization. Leptin-mediated reduction in F-actin levels was previously shown to be dependent on basal PI3K activity and inhibition of both lipid and protein phosphatase activity of PTEN (12). Correspondingly, overexpression of the PTEN phosphorylation site mutants, S370A PTEN and T366A PTEN, in N29/4 cells occluded leptin-driven reduction in F-actin. The Thr-366 and Ser-370 alanine and aspartic acid PTEN mutants, when overexpressed in N29/4 cells, alter PtdIns(3,4,5)P3 levels exactly as reported for the cluster site mutants. This outcome does not agree with in vitro assays, which show no alteration in enzyme activity associated with these mutants (41), unlike the corresponding mutations of the cluster site residues (12). Thus, S370D and T366D both raised PtdIns(3,4,5)P3 levels, indicative of reduced lipid phosphatase activity per se and dominant negative behavior with respect to native PTEN activity. Interestingly, these mutants produced different outcomes on F-actin levels and leptin signal transduction. Overexpression of T366D PTEN per se mimicked the effects of leptin by increasing PtdIns(3,4,5)P3 and inducing F-actin depolymerization in a PI3K-dependent manner. This replicates the effect of overexpression of C124S PTEN and D3PTEN (cluster site mutant) in these cells (12) and is consistent with phosphorylation of the Thr-366 site reducing PTEN lipid and protein phosphatase activity. In contrast, overexpression of S370D PTEN was unable to elicit F-actin depolymerization per se even in the face of increased cellular PtdIns(3,4,5)P3 levels and did not occlude leptin-mediated F-actin depolymerization. Consequently, mimicking phosphorylation by aspartate substitution at Ser-370 does not exactly replicate the effect of aspartate substitution at Thr-366 or the cluster phosphorylation site (12), with all three mutant forms of PTEN increasing PtdIns(3,4,5)P3 levels but only the latter two reducing F-actin levels. The S370D PTEN mutant also does not duplicate the action of the lipid phosphatase dead, protein phosphatase active, mutant G129E PTEN. Overexpression of G129E PTEN in N29/4 cells increases PtdIns(3,4,5)P3 levels with no reduction in F-actin and prevents leptin-mediated F-actin depolymerization (12), whereas the presence of S370D PTEN allows leptin depolymerization of actin. Our conclusion from these data is that S370D is lipid phosphatase dead but protein phosphatase active and that leptin inhibits the protein phosphatase activity by phosphorylation at the Thr-366 and cluster sites, whereas the protein phosphatase activity of G129E PTEN cannot be overcome by phosphorylation at these sites. Thus, phosphorylation of PTEN at Ser-370 is adequate to inhibit PTEN lipid phosphatase activity and increase PtdIns(3,4,5)P3 in N29/4 cells but is not sufficient per se for efficacious transmission of the leptin signal to F-actin.
###end p 36
###begin p 37
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 97 9 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin and insulin increase PKB and GSK3 serine phosphorylation in N29/4 and MIN6 cells.</bold>
###xml 112 113 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 236 237 236 237 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 252 253 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 263 264 263 264 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 280 281 280 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 322 356 322 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs below each set of blots</italic>
###xml 463 464 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 483 484 483 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 518 519 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 532 533 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 535 536 535 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 544 545 544 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 605 609 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cont</italic>
###xml 9 619 9 619 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38"><bold>Leptin and insulin increase PKB and GSK3 serine phosphorylation in N29/4 and MIN6 cells.</bold> PKB (Ser-473 (<italic>S</italic>)) and GSK3 (Ser-9/Ser-21) phosphorylation was determined in N29/4 (<italic>A</italic> and <italic>B</italic>) and MIN6 (<italic>C</italic> and <italic>D</italic>) cells, stimulated with 10 n<sc>m</sc> leptin (<italic>A</italic> and <italic>C</italic>), or 10 n<sc>m</sc> insulin (<italic>B</italic> and <italic>D</italic>) for the indicated times (minutes). The <italic>bar graphs below each set of blots</italic> show mean normalized p-PKB and p-GSK3 levels for untreated cells and cells stimulated with leptin (N29/4 (<italic>A</italic>, <italic>n</italic> = 9), MIN6 (<italic>C</italic>, <italic>n</italic> = 6)) or with insulin (N29/4 (<italic>B</italic>, <italic>n</italic> = 9), MIN6 (<italic>D</italic>, <italic>n</italic> = 6)). <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control level for each treatment. <italic>Cont</italic>, control.</p>
###xml 9 619 9 619 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38"><bold>Leptin and insulin increase PKB and GSK3 serine phosphorylation in N29/4 and MIN6 cells.</bold> PKB (Ser-473 (<italic>S</italic>)) and GSK3 (Ser-9/Ser-21) phosphorylation was determined in N29/4 (<italic>A</italic> and <italic>B</italic>) and MIN6 (<italic>C</italic> and <italic>D</italic>) cells, stimulated with 10 n<sc>m</sc> leptin (<italic>A</italic> and <italic>C</italic>), or 10 n<sc>m</sc> insulin (<italic>B</italic> and <italic>D</italic>) for the indicated times (minutes). The <italic>bar graphs below each set of blots</italic> show mean normalized p-PKB and p-GSK3 levels for untreated cells and cells stimulated with leptin (N29/4 (<italic>A</italic>, <italic>n</italic> = 9), MIN6 (<italic>C</italic>, <italic>n</italic> = 6)) or with insulin (N29/4 (<italic>B</italic>, <italic>n</italic> = 9), MIN6 (<italic>D</italic>, <italic>n</italic> = 6)). <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control level for each treatment. <italic>Cont</italic>, control.</p></caption>
###xml 619 619 619 619 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972430005"/>
###xml 0 619 0 619 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="38"><bold>Leptin and insulin increase PKB and GSK3 serine phosphorylation in N29/4 and MIN6 cells.</bold> PKB (Ser-473 (<italic>S</italic>)) and GSK3 (Ser-9/Ser-21) phosphorylation was determined in N29/4 (<italic>A</italic> and <italic>B</italic>) and MIN6 (<italic>C</italic> and <italic>D</italic>) cells, stimulated with 10 n<sc>m</sc> leptin (<italic>A</italic> and <italic>C</italic>), or 10 n<sc>m</sc> insulin (<italic>B</italic> and <italic>D</italic>) for the indicated times (minutes). The <italic>bar graphs below each set of blots</italic> show mean normalized p-PKB and p-GSK3 levels for untreated cells and cells stimulated with leptin (N29/4 (<italic>A</italic>, <italic>n</italic> = 9), MIN6 (<italic>C</italic>, <italic>n</italic> = 6)) or with insulin (N29/4 (<italic>B</italic>, <italic>n</italic> = 9), MIN6 (<italic>D</italic>, <italic>n</italic> = 6)). <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control level for each treatment. <italic>Cont</italic>, control.</p></caption><graphic xlink:href="zbc0190972430005"/></fig>
FIGURE 5.Leptin and insulin increase PKB and GSK3 serine phosphorylation in N29/4 and MIN6 cells. PKB (Ser-473 (S)) and GSK3 (Ser-9/Ser-21) phosphorylation was determined in N29/4 (A and B) and MIN6 (C and D) cells, stimulated with 10 nm leptin (A and C), or 10 nm insulin (B and D) for the indicated times (minutes). The bar graphs below each set of blots show mean normalized p-PKB and p-GSK3 levels for untreated cells and cells stimulated with leptin (N29/4 (A, n = 9), MIN6 (C, n = 6)) or with insulin (N29/4 (B, n = 9), MIN6 (D, n = 6)). *, p < 0.05, compared with control level for each treatment. Cont, control.
###end p 37
###begin p 38
###xml 0 88 0 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin and insulin increase PKB and GSK3 serine phosphorylation in N29/4 and MIN6 cells.</bold>
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 227 228 227 228 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 254 255 254 255 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 313 347 313 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs below each set of blots</italic>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 471 472 471 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 474 475 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 506 507 506 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 509 510 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 538 539 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cont</italic>
Leptin and insulin increase PKB and GSK3 serine phosphorylation in N29/4 and MIN6 cells. PKB (Ser-473 (S)) and GSK3 (Ser-9/Ser-21) phosphorylation was determined in N29/4 (A and B) and MIN6 (C and D) cells, stimulated with 10 nm leptin (A and C), or 10 nm insulin (B and D) for the indicated times (minutes). The bar graphs below each set of blots show mean normalized p-PKB and p-GSK3 levels for untreated cells and cells stimulated with leptin (N29/4 (A, n = 9), MIN6 (C, n = 6)) or with insulin (N29/4 (B, n = 9), MIN6 (D, n = 6)). *, p < 0.05, compared with control level for each treatment. Cont, control.
###end p 38
###begin p 39
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 98 9 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin, but not insulin, increases GSK3 tyrosine phosphorylation in N29/4 and MIN6 cells.</bold>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 167 168 167 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 221 222 221 222 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 248 249 248 249 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 306 340 306 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs below each set of blots</italic>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 434 435 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 499 500 499 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 502 503 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 510 511 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 571 572 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 618 619 618 619 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 634 635 634 635 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 660 669 660 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 821 822 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cont</italic>
###xml 9 852 9 852 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40"><bold>Leptin, but not insulin, increases GSK3 tyrosine phosphorylation in N29/4 and MIN6 cells.</bold> GSK3 (Tyr-216/Tyr-279 (<italic>Y</italic>)) phosphorylation was determined in N29/4 (<italic>A</italic> and <italic>B</italic>) and MIN6 cells (<italic>C</italic> and <italic>D</italic>) stimulated with 10 n<sc>m</sc> insulin (<italic>A</italic> and <italic>C</italic>) or 10 n<sc>m</sc> leptin (<italic>B</italic> and <italic>D</italic>) for the indicated times (minutes). The <italic>bar graphs below each set of blots</italic> show mean normalized p-GSK3 for untreated cells and cells stimulated with insulin (N29/4 (<italic>A</italic>, <italic>n</italic> = 9), MIN6 (C, <italic>n</italic> = 6)) or with leptin (N29/4 (<italic>B</italic>, <italic>n</italic> = 9), MIN6 (<italic>D</italic>, <italic>n</italic> = 6). <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control level for each treatment. <italic>E</italic>, N29/4 cells were stimulated with either 10 n<sc>m</sc> leptin or 50 n<sc>m</sc> insulin for 30 min. The <italic>bar graph</italic> denotes the mean normalized GSK3 activity and shows that insulin significantly inhibited GSK3 activity, whereas leptin had no effect on GSK3 activity (<italic>n</italic> = 3 for each). <italic>Cont</italic>, control.</p>
###xml 9 852 9 852 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40"><bold>Leptin, but not insulin, increases GSK3 tyrosine phosphorylation in N29/4 and MIN6 cells.</bold> GSK3 (Tyr-216/Tyr-279 (<italic>Y</italic>)) phosphorylation was determined in N29/4 (<italic>A</italic> and <italic>B</italic>) and MIN6 cells (<italic>C</italic> and <italic>D</italic>) stimulated with 10 n<sc>m</sc> insulin (<italic>A</italic> and <italic>C</italic>) or 10 n<sc>m</sc> leptin (<italic>B</italic> and <italic>D</italic>) for the indicated times (minutes). The <italic>bar graphs below each set of blots</italic> show mean normalized p-GSK3 for untreated cells and cells stimulated with insulin (N29/4 (<italic>A</italic>, <italic>n</italic> = 9), MIN6 (C, <italic>n</italic> = 6)) or with leptin (N29/4 (<italic>B</italic>, <italic>n</italic> = 9), MIN6 (<italic>D</italic>, <italic>n</italic> = 6). <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control level for each treatment. <italic>E</italic>, N29/4 cells were stimulated with either 10 n<sc>m</sc> leptin or 50 n<sc>m</sc> insulin for 30 min. The <italic>bar graph</italic> denotes the mean normalized GSK3 activity and shows that insulin significantly inhibited GSK3 activity, whereas leptin had no effect on GSK3 activity (<italic>n</italic> = 3 for each). <italic>Cont</italic>, control.</p></caption>
###xml 852 852 852 852 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0190972430006"/>
###xml 0 852 0 852 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="40"><bold>Leptin, but not insulin, increases GSK3 tyrosine phosphorylation in N29/4 and MIN6 cells.</bold> GSK3 (Tyr-216/Tyr-279 (<italic>Y</italic>)) phosphorylation was determined in N29/4 (<italic>A</italic> and <italic>B</italic>) and MIN6 cells (<italic>C</italic> and <italic>D</italic>) stimulated with 10 n<sc>m</sc> insulin (<italic>A</italic> and <italic>C</italic>) or 10 n<sc>m</sc> leptin (<italic>B</italic> and <italic>D</italic>) for the indicated times (minutes). The <italic>bar graphs below each set of blots</italic> show mean normalized p-GSK3 for untreated cells and cells stimulated with insulin (N29/4 (<italic>A</italic>, <italic>n</italic> = 9), MIN6 (C, <italic>n</italic> = 6)) or with leptin (N29/4 (<italic>B</italic>, <italic>n</italic> = 9), MIN6 (<italic>D</italic>, <italic>n</italic> = 6). <sup>*</sup>, <italic>p</italic> &lt; 0.05, compared with control level for each treatment. <italic>E</italic>, N29/4 cells were stimulated with either 10 n<sc>m</sc> leptin or 50 n<sc>m</sc> insulin for 30 min. The <italic>bar graph</italic> denotes the mean normalized GSK3 activity and shows that insulin significantly inhibited GSK3 activity, whereas leptin had no effect on GSK3 activity (<italic>n</italic> = 3 for each). <italic>Cont</italic>, control.</p></caption><graphic xlink:href="zbc0190972430006"/></fig>
FIGURE 6.Leptin, but not insulin, increases GSK3 tyrosine phosphorylation in N29/4 and MIN6 cells. GSK3 (Tyr-216/Tyr-279 (Y)) phosphorylation was determined in N29/4 (A and B) and MIN6 cells (C and D) stimulated with 10 nm insulin (A and C) or 10 nm leptin (B and D) for the indicated times (minutes). The bar graphs below each set of blots show mean normalized p-GSK3 for untreated cells and cells stimulated with insulin (N29/4 (A, n = 9), MIN6 (C, n = 6)) or with leptin (N29/4 (B, n = 9), MIN6 (D, n = 6). *, p < 0.05, compared with control level for each treatment. E, N29/4 cells were stimulated with either 10 nm leptin or 50 nm insulin for 30 min. The bar graph denotes the mean normalized GSK3 activity and shows that insulin significantly inhibited GSK3 activity, whereas leptin had no effect on GSK3 activity (n = 3 for each). Cont, control.
###end p 39
###begin p 40
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Leptin, but not insulin, increases GSK3 tyrosine phosphorylation in N29/4 and MIN6 cells.</bold>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 212 213 212 213 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 239 240 239 240 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 297 331 297 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graphs below each set of blots</italic>
###xml 422 423 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 425 426 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 442 443 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">*</sup>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 609 610 609 610 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 625 626 625 626 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 651 660 651 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bar graph</italic>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cont</italic>
Leptin, but not insulin, increases GSK3 tyrosine phosphorylation in N29/4 and MIN6 cells. GSK3 (Tyr-216/Tyr-279 (Y)) phosphorylation was determined in N29/4 (A and B) and MIN6 cells (C and D) stimulated with 10 nm insulin (A and C) or 10 nm leptin (B and D) for the indicated times (minutes). The bar graphs below each set of blots show mean normalized p-GSK3 for untreated cells and cells stimulated with insulin (N29/4 (A, n = 9), MIN6 (C, n = 6)) or with leptin (N29/4 (B, n = 9), MIN6 (D, n = 6). *, p < 0.05, compared with control level for each treatment. E, N29/4 cells were stimulated with either 10 nm leptin or 50 nm insulin for 30 min. The bar graph denotes the mean normalized GSK3 activity and shows that insulin significantly inhibited GSK3 activity, whereas leptin had no effect on GSK3 activity (n = 3 for each). Cont, control.
###end p 40
###begin p 41
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref42">42</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 1272 1274 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref44">44</xref>
###xml 1509 1511 1509 1511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 1513 1515 1513 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
###xml 1636 1638 1636 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 1707 1709 1707 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 2324 2332 2321 2329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 2565 2567 2562 2564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 2725 2728 2722 2725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 2795 2801 2792 2798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 2968 2971 2962 2965 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 3262 3265 3256 3259 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
A number of phosphorylation sites have been identified within the PTEN C-terminal tail, with the protein kinase, CK2, purported to phosphorylate multiple residues, including the cluster site, Ser-385 and Ser-370, but not Thr-366 (17-19, 23, 41). PTEN protein stability and activity are considered to be dependent on phosphorylation status of the C-terminal tail (17, 18), with phosphorylation argued to reduce association of PTEN with the plasma membrane (20, 42, 43). It is presently unclear what effect leptin-induced phosphorylation will have on PTEN protein stability, as it has been reported that T366A and S370A are more stable than wild-type PTEN and GSK3 inhibition increases the stability of wild-type PTEN (41), whereas alanine mutation of the cluster site results in reduced protein stability (17, 19). The inhibition of leptin-induced phosphorylation of the cluster site (12), Ser-370 and Ser-385, in N29/4 cells and of the cluster site and Ser-370 in MIN6 cells by DMAT supports the view that CK2 is the kinase responsible for phosphorylation at these sites by this hormone. Inhibition of PI3K had no effect on leptin-mediated phosphorylation at Ser-370, Ser-385, or Thr-366 in N29/4 cells, indicating no evidence for PI3K-dependent feedback phosphorylation (44) consistent with leptin-induced phosphorylation of the cluster site. For GSK3 to phosphorylate its substrate, the substrate has to be primed by phosphorylation of a site four or five residues C-terminal of the target Ser/Thr of GSK3 (45, 46). Thus, phosphorylation of Ser-370 by CK2 is considered a priming event for subsequent GSK3 phosphorylation of Thr-366 (23), and inhibition of GSK3 blocks phosphorylation of PTEN on Thr-366 (41). Occlusion of leptin driven-increased p-PTEN on Thr-366 by the GSK3 inhibitor CT99021 in N29/4 and MIN6 cells agrees with these findings. Consequently, we expected DMAT to reduce or inhibit leptin-mediated phosphorylation of Thr-366 in these cells. This was observed for MIN6 pancreatic beta-cells but not for the hypothalamic cells, where DMAT prevented leptin-induced phosphorylation of Ser-370 but not Thr-366. Thus, either an additional unidentified priming kinase is responsible or there is sufficient phosphorylation of Ser-370 remaining in DMAT-treated N29/4 cells to allow GSK3 priming. Interestingly, an in vitro study of PTEN phosphorylation has shown that phosphorylation of Ser-370 by CK2 is less efficient than that of the cluster site and that GSK3 is capable of phosphorylating PTEN at Thr-366 without priming, although at low efficiency (41). Thus, we predicted that inhibition of CK2 and GSK3 would prevent or reduce transmission of the leptin signal via PTEN to actin filament restructuring and KATP channel opening. Our results show that the GSK3 inhibitor CT99021 per se or in combination with DMAT significantly reduces leptin-mediated F-actin depolymerization. Furthermore, leptin-driven hyperpolarization of pancreatic beta-cells by KATP activation was prevented by the presence of DMAT or any one of three structurally dissimilar GSK3 inhibitors. This is consistent with the view that leptin-mediated phosphorylation of PTEN and subsequent inhibition of its phosphatase activity is a necessary step for signal transmission to KATP channels.
###end p 41
###begin p 42
###xml 136 139 133 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 205 207 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 958 960 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 1841 1845 1838 1842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 1890 1894 1887 1891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
In contrast, insulin does not cause F-actin depolymerization in N29/4 cells nor does it hyperpolarize pancreatic beta-cells by opening KATP channels, and this differential output may be mediated via PTEN (12). The results presented here indicate a key role for PTEN Thr-366 phosphorylation via GSK3 activity for successful transmission of the leptin signal. For this to occur, GSK3 activity has to be maintained or increased by leptin. However, leptin, like insulin, increases PKB phosphorylation with the resultant phosphorylation of GSK3 at Ser-9/Ser-21 consistent with inhibition of GSK3 activity. Indeed, both insulin and leptin increased the phosphorylation of GSK3 at Ser-9/Ser-21 in N29/4 and MIN6 cells. In contrast, leptin, but not insulin, caused a rapid and sustained increase in GSK3 phosphorylation at Tyr-216/Tyr-279 in both cell types. Phosphorylation of GSK3 at this site is considered to be activating and necessary for functional activity (38). Indeed, direct GSK3 kinase assay showed that insulin stimulation of N29/4 cells substantially reduced GSK3 activity, whereas leptin had no effect. Taken together, the semiquantitative Western blot data show that insulin significantly alters N-terminal serine phosphorylation of GSK3, which would reduce its activity toward primed substrates. However, phosphorylation of PTEN at Thr-366 in response to leptin does not appear to require priming (phosphorylation of this site is unaffected by DMAT), and this may explain why insulin does not reduce Thr-366 phosphorylation. In contrast, GSK3 in leptin-treated cells increased phosphate in Tyr-216/Tyr-279 compared with control or insulin-treated cells. This is a possible explanation why leptin and not insulin induces Thr-366 phosphorylation. However, there are other ways to regulate GSK3, including protein-protein interaction (e.g. Wnt signaling) and Thr-380 phosphorylation (e.g. cytokine signaling) that also require further investigation. Identification of the kinase (or phosphatase) responsible for the increase in tyrosine phosphorylation of GSK3 and development of a quantitative multiple reaction monitoring liquid chromatographymass spectrometric approach for each of the phosphorylation sites on GSK3 would be required to elucidate the exact mechanism of control by leptin. These subtle signaling differences downstream of insulin and leptin receptors are likely to contribute to the ability of each to perform their distinct physiological actions through modulation of the same signaling pathways/molecules.
###end p 42
###begin p 43
###xml 284 287 284 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 473 476 473 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink">ATP</sub>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 1311 1313 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 1424 1426 1424 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1459 1463 1459 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e.g.</italic>
###xml 1483 1485 1483 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 403 408 <span type="species:ncbi:10090">mouse</span>
In conclusion, this study has demonstrated that leptin increases the phosphorylation of PTEN at multiple residues in a CK2- and GSK3-dependent manner. This action of leptin is required for successful transmission of the leptin signal to cause cytoskeletal remodeling, the opening of KATP channels, and subsequent hyperpolarization of membrane potential. Interestingly, complete loss of PTEN activity in mouse hypothalamic proopiomelanocortin neurons permanently activates KATP channels and hyperpolarizes the neurons resulting in hyperphagia, leptin resistance, and diet-induced obesity (10). The role of GSK3 in PTEN regulation is intriguing. Insulin signaling inhibits GSK3 activity, and this may act via an alteration in PTEN Thr-366 phosphorylation as a negative feedback loop for leptin signaling in cells. In contrast, leptin, regardless of whether it stimulates PI3K activity in all cells or not, by maintaining GSK3 activity may result in a positive feedback to PI3K signaling in cells. Such interplay between leptin and insulin signaling in cells may have important implications for downstream signaling events. For example, inhibition of PTEN in peripheral tissues such as liver, muscle, and fat demonstrate improved insulin sensitivity and systemic glucose tolerance under normal and high fat diets (48). Dysregulation of PTEN (lipid and protein phosphatase) activity has also been implicated in certain cancers (49) and neurodegenerative disease (e.g. Parkinson disease (47)). Thus, modulation of PTEN function plays multiple and important roles in numerous physiological and pathological phenomena.
###end p 43
###begin p 44
We thank Dr. Nick Leslie for providing the PTEN mutants and PTEN Ser-370 and Thr-366 phospho-antibodies and for helpful comments.
###end p 44
###begin p 45
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
The abbreviations used are: PI3K, phosphatidylinositol 3-kinase; DMAT, 2-dimethyl-amino-4,5,6,7-tetrabromo-1H-benzimidazole; p-, phosphorylated; PtdIns(3,4,5)P3, phosphatidylinositol-3,4,5-trisphosphate; PKB, protein kinase B; GSK3, glycogen synthase kinase 3.
###end p 45

